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Abstract 
DNA released into the cytoplasm as a consequence of microbial infection or pathology 
can be recognized by the host sensor, Absent in melanoma (AIM) 2 that leads to the 
assembly and activation of the inflammasome complex and cyclic GMP-AMP synthase 
(cGAS) that induces type-I Interferon (IFN) production. Inflammasome activated 
caspase-1 cleaves gasdermin-D leading to pore-formation in the plasma membrane that 
subsequently results in pyroptosis. In this study we found that activated gasdermin-D 
negatively regulates cGAS-induced type-I IFN production in a pyroptosis and interleukin 
(IL)-1β and IL-18 independent manner. Mechanistic studies showed that gasdermin-D 
pore formation lead to a loss of intracellular potassium (K+) concentration that 
suppressed the production of cGAS-induced type-I IFN. Therefore, we report a novel 
regulatory mechanism for cGAS/STING-induced type-I IFN that may have profound 
therapeutic implications in autoimmune diseases and anti-tumor immunotherapy. 
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Chapter I 
Introduction 
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A. Cytosolic DNA Sensors 
 
The presence of DNA in the cytosol is highly immunostimulatory. A variety of host 
sensors recognize DNA in the cytosol. The earliest known DNA sensor is the 
endosomal Toll like receptor (TLR 9). TLR9 recognizes unmethylated CpG rich DNA 
and is highly expressed in plasmacytoid dendritic cells (pDCSs) (Ahmad-Nejad et al., 
2000; Hemmi et al., 2000; Latz et al., 2004; Yasuda et al., 2009). Engagement of DNA 
ligand by TLR9 leads to the production of type-I IFN. Apart from the endosomal TLR9, 
there are many sensors that bind DNA in the cytosol. Prominent among them are AIM2 
and cGAS. They bind the sugar phosphate groups in DNA therefore DNA recognition is 
sequence independent. While, AIM2 activation unlike other DNA sensors results in the 
activation and assembly of the inflammasome complex in response to DNA recognition, 
cGAS activation leads to the production of type-I IFN (Albrecht et al., 2005; Sun et al., 
2013).  
 
There are other DNA sensors that shuttle between the nucleus and the cytosol. Many 
proteins that function as a part of the DNA damage repair pathway also function as host 
defense sensors of DNA. The Mre11-Rasd50-Nbs (MRN) complex senses double-
stranded breaks (DSBs) and also binds DNA in the cytosol in a sequence independent 
manner resulting in the production of type-I IFN (Kanaar et al.,2008; Roth et al, 2014). 
Other DNA repair proteins involved in host response to DNA include RNA Polymerase 
III and IFN -inducible gene 16 (IFI16) (Ablasser et al., 2009; Chiu et al., 2009; Kerur et 
al., 2011; Unterholzner et al., 2010). 
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Some RNA helicases such as DHX9, DHX36, DDX41 and DDX60 can also bind DNA 
and lead to type-I IFN production in response to it (Kim et al., 2010; Zhang et al., 2011 
and Miyashita et al., 2011). 
 
B. AIM2 and the Inflammasome complex 
 
Inflammasomes are cytosolic multiprotein complexes that have the ability to trigger an 
inflammatory cascade. Members of the nucleotide-binding domain and leucine-rich 
repeats receptor (NLR) and absent in melanoma receptor (ALR) family are most 
commonly known to form inflammasome complexes. Of the NLR family NLRP1, NLRP3 
and NLRC4 activation upon recognition of stimuli leads to assembly of the 
inflammasome complex. While in the ALR family AIM2 oligomerizes into an 
inflammasome macrmolecular structure in response to stimuli (Lamkanfi and 
Dixit.,2014). NLRs or ALRs on ligand stimulation and activation recruits a bipartite 
protein, apoptosis-associated speck like protein containing a caspase activation and 
recruitment domain (ASC) (Fernandes-Alnemri et al., 2007; Huang et al., 2009). ASC 
recruits caspase-1 using its CARD domain. Caspase-1 further cleaves pro-IL-1β and 
pro IL-18 into their mature forms that are subsequently released from the cell (Broz et 
al., 2010). 
 
AIM2 recognizes double-stranded DNA and oligomerizes in response to it. AIM2 is part 
of the ALR family of proteins that contains two structural domains, the PYD domain and 
the HIN200 domain (Albrecht et al., 2005). The HIN200 domain binds DNA (Ludlow et 
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al., 2005). The PYD domain of AIM2 can recognize other PYD containing proteins. 
Therefore, on activation AIM2 can recruit ASC by PYD-PYD interactions (Fernandes- 
Alnemhri et al., 2009; Hornung et al., 2009). 
 
A variety of microbial pathogens including viruses like mouse cytomegalovirus (MCMV), 
vaccinia virus and cytomegalovirus and intracellular bacteria like Francisella tularensis, 
Listeria monocytogenes and Mycobacterium tuberculosis can result in the activation of 
the AIM2 inflammasome (Jones et al., 2010; Rathinam et al., 2010; Warren et al., 
2010). In intracellular bacterial infections pathogenic DNA can be released in the 
cytosol. Francisella can escape the phagosome and undergo baceriolysis resulting in 
the release of bacterial DNA in the cytosol. Francisella DNA activates other host DNA 
sensors leading to the production of type I IFN s and the up-regulation of ISGs such as 
IRF1. IRF1 further controls the expression of GTPases, guanylate binding proteins 
(GBPs) GBP 2 and 5 along with another IFN inducible protein IRGB10 induce bacterial 
killing (Man et al 2015; Man et al., 2016; Muenier et al., 2015).  Mice deficient in 
IRGB10 and GBP along with inflammasome components AIM2 and caspase-1 have 
increased susceptibility to Francisella infections (Man et al., 2016). 
 
Some pathological conditions such as cancer can result in damage to the nuclear 
compartment. This can result in the presentation of the nuclear material to cytoplasmic 
host sensors. Nuclear host DNA can thus be recognized by cytoplasmic DNA sensors 
cGAS and AIM2 (Di Micco et al., 2016). Activation of the inflammasome pathway by 
self-DNA can lead to the development of autoinflammatory diseases such as 
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polyarthritis like symptoms caused in DNase II deficient mice (Baum et al 2015; Jakobs 
et al., 2015). 
 
AIM2 activation results in the recruitment of the adapter protein ASC and caspase-1. 
Caspase-1 proteolytically cleaves the pro-inflammatory cytokines IL-1β and IL-18 into 
their active forms. The activation of caspase-1 also results in the death of the cell. 
Caspase-1 cleaves gasdermin-D that has recently been identified as the mediator of 
pyroptotic cell death. Pyroptosis is a form of inflammatory cell death that results in the 
release of contents from the cytosol. This further triggers the excretion of 
proinflammatory mediators and danger signals from the cell leading to an amplification 
of the host immune response. 
 
 
C. Gasdermin (GSDM): Activation and Pyroptosis 
 
GSDM are a family of proteins with mice encoding 10 GSDM proteins and humans 
encoding 6. Gasdermin family in mice include GSDMA 1-3, GSDMC (1-4), GSDMD, 
GSDME and PJVK while the human loci encodes GSDMA, GSDMB, GSDMD, 
GSDMDC1, DFNA5, GSDME and PJVK. GSDMD has recently been identified as a 
substrate of inflammasome activation by three independent research groups. In their 
2015 study Shi et al used clustered regularly interspaced short palindromic repeats 
(CRISPR-Cas9) system to screen for genes involved in caspase-1 and caspase-11 
dependent pyroptosis. They found that mutations in GSDMD made the BMDMs 
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resistant to pyroptosis in response to inflammasome stimuli. This was accompanied by 
reduced IL-1β secretion by these BMDMs (Shi et al., 2015). Furthermore, another 
research group used an ethyl-nitrosourea (ENU) mutagenesis approach to study the 
proteins involved in caspase-11 dependent pyroptosis. They found that LPS stimulated 
BMDMs from mice carrying I105N mutation in GSDMD protein were less susceptible to 
caspase-11 dependent pyroptosis. Although upon prolonged treatment, GSDMD 
deficient cells eventually undergo cell death by apoptosis (Kayagaki et al., 2015). A third 
study also independently reinforced these findings (He et al., 2015). 
 
GSDMD can be cleaved into its C-terminus and N-terminus domain by the inflammatory 
caspases-1,4.5 and 11(He et al., 2015; Kayagaki et al., 2015; Shi et al., 2015). GSDMD 
N-terminus can bind to lipids in the plasma membrane. It can bind to phosphatidyl 
inositol phosphates (PIPs) such as PI4P, PI(4,5)P2, PI3P and PI5P(Ding et al., 2016; 
Liu et al., 2016). However GSDMD N-terminus cannot bind to phosphatidyl 
ethanolamine and phosphatidyl choline that are prominent in the outer surface of the 
plasma membrane lipid bilayer (Liu et al., 2016). This prevents the death of bystander 
cells in an inflammatory environment. Interestingly GSDMD binds cardiolipin on the 
bacterial outer membrane (Liu et al., 2016). This results in the lysis and killing of 
bacteria such as Escherichia coli, Staphylococcus aureus and Listeria monocytogens 
(Liu et al., 2016). 
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The size of the GSDMD pore formed is 10 -16 nm wide. The pore is non-selective and 
molecules with a smaller size can be released through the pore while higher molecular 
size proteins are restricted. 
The active forms of pro-inflammatory cytokines such as IL-1β and IL-18 have a 
molecular size of 4 nm and are hence released through the GSDMD pore (Ding et al., 
2016 and Liu et al., 2016). Lactate dehydrogenase (LDH) on the other hand is a 
tetrameric molecule with a molecular size of 10 nm and is restricted (Evavold et al., 
2018). Whether cells that have a certain threshold of GSDMD pores proceed towards 
pyroptosis requires further investigation in the field. 
 
GSDMD is associated with functions apart from its role in cell death. The release of 
caspase-1 cleaved mature IL-1β and IL-18 from the cell in the absence of cell lysis was 
shown prior to the discovery of GSDMD in 2006 (Fink and Cookson, 2006). A recent 
study further corroborated this by demonstrating the role of GSDMD pores in the 
release of IL-1β in the absence of cell lysis (Evavold et al., 2018). The study uses an 
osmoprotectant glycine that blocks cell lysis measured by LDH release but allows the 
formation of GSDMD pores assessed by the entry of propidium iodide in the cell. On 
treatment of primary macrophages with inflammasome activating stimuli, bioactive IL-1β 
is released through the GSDMD pores even though glycine treatment blocks cell lysis 
and LDH release. Furthermore, treatment with stimuli that do not cause pyroptosis but 
lead to inflammasome dependent gasdermin-D activation and pore formation such as 
bacterial peptidoglycan, the peptidoglycan component N-acetyl glucosamine (NAG), S. 
aureus O-acetyl transferase A (Oat A) mutant leads to IL-1β release through the 
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GSDMD pores in the absence of cell lysis (Evavold et al., 2018). A similar phenotype is 
observed in other myeloid cell types such as primary dendritic cells (DCs). In bone 
marrow derived dendritic cells (BMDCs), treatment with oxidized phospholipids 
(OxPAPC) results in the release of IL-1β in the absence of pyroptosis (Hellig et al., 
2018). These studies demonstrate the role of gasdermin-D in secretion of bioactive pro-
inflammatory cytokines in viable cells. 
 
These studies however fail to establish the kinetics of cytokine release and cell death. 
More investigation is required to establish the sequential events leading to pyroptosis. 
Prolonging this window period between the formation of GSDMD pore formation and the 
lysis of the cell leads to the enhanced release of inflammatory mediators from the cell 
and also results in increased T cell priming and antigen-specific response (Gong et al., 
2017; Zamoin et al., 2016). Recent studies have also shown that IL-1β can be released 
from the cell in a GSDMD dependent or independent manner. The early release of IL-1β 
in inflammasome activated non-pyroptotic cells is dependent on GSDMD secretion at 
later stages is independent of it (Monteleone et al., 2018; Schneider et al., 2017). 
Neutrophils express GSDMD to a lesser extent than macrophages and dendritic cells 
and can release cleaved IL-1β even from GSDMD lacking neutrophils (Hellig et al., 
2018). 
 
Apart from its role in the secretion of cytokines GSDMD is also essential for the 
formation of neutrophil extracellular traps (NETs) against extracellular microbes. NETS 
are composed of chromatin and anti-microbial compounds. On the recognition of LPS 
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from extracellular gram-negative bacteria by neutrophils the non-canonical 
inflammasome signaling is activated resulting in the activation and cleavage of caspase-
11 and GSDMD. The activation of GSDMD in neutrophils is indispensable to the 
formation of NETs. GSDMD is required in mediating the early events in the formation of 
NETs such as nuclear membrane disruption and histone degradation that results in 
nuclear expansion along with the final stage events such as cell lysis and NET extrusion 
(Chen et al., 2018; Sollberger et al., 2018). Blocking the formation of NETs by 
deoxyribonuclease–I treatment in Salmonella sifA mutant infection that stimulates the 
caspase-11 inflammasome by its LPS, leads to higher bacterial burdens in wild type 
mice. However, a similar phenotype is not seen with Casp-11-/- and GSDMD-/- mice 
(Chen et al., 2018). 
 
D. Other Gasdermin family members 
 
GSDMA 
 
GSDMA, has been the most studied GSDM family protein after GSDMD. It is encoded 
as a single protein GSDMA in the human genome while the mouse genome encodes 
three proteins GSDMA 1-3. GSDMA has a structure similar to GSDMD. It has an N and 
a C-terminus domain, with the N-terminus being auto-inhibited by the C-terminus. Due 
to its structural similarity with GSDMD, it was predicted that GSDMA could also form 
membrane pores. When over-expressed in 293T cells GSDMA and GSDMA3 can form 
pores in the plasma membrane and result in cell lysis by pyroptosis, thereby causing 
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cytotoxicity (Ding et al., 2016). Although, this has not been reported thus far in a 
physiological system. However, GSDMA has been shown to form pores in the 
mitochondrial membrane (Lin et al., 2015; Shi et al., 2015). The N-terminal domain of 
GSDMA3 can interact with and inhibit TRAP1, a mitochondrial chaperone that aids in 
reducing mitochondrial permeability and apoptosis (Shi et al., 2015). 
 
Mutations in GSDMA that results in the release of N-terminus inhibition are associated 
with a variety of disease phenotypes such as alopecia, cutaneous inflammation, 
heightened immune responses and enlarged spleen, hyperplasia (Ding et al., 2016; 
Guo et al., 2017; Kumar et al., 2012; Wood et al., 2005; Zhou et al., 2012). The Y344H 
mutation that abrogates the N-terminus auto-inhibition has been investigated in some 
depth. The Y344H mutation is associated with the previously described phenotype of 
enlarged lymph nodes and aggressive immune responses  (Guo et al., 2017; Wood et 
al., 2005). This mutation in GSDMA3 is associated with a decrease in caspase-3 
expression thereby leading to reduced apoptosis in keratinocytes (Lei et al., 2012). 
Also, the Y344H mutation leads to the reduction in mitochondrial membrane potential 
and increased reactive oxygen species (ROS) generation (Shi et al., 2015). 
 
GSDMB 
In contrast to the other members of the gasdermin family GSDMB is carried by humans 
but not mice (Runkel et al., 2004).  GSDMB also differs from other family members due 
to its membrane binding ability. The N-terminus as well as the full-length GSDMB 
protein can bind to membrane lipids such as phosphoinositides and glycolipids (Chao et 
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al., 2017). However only the N-terminal GSDMB fragment can form poresin the plasma 
membrane and induce pyroptosis (Ding et al., 2016). The cleavage of GSDMB is 
controversial. One study reports the cleavage of GSDMB by apoptotic caspases-3 and 
7 instead of caspase-1, 4 or 5 (Chao et al., 2017). While another contrasting group has 
demonstrated the cleavage of GSDMB by inflammatory caspase-1 (Panganiban et al., 
2018). Although the later study uses overexpression of GSDMB and caspase-1 in HEK 
293T cells as their model system and this may not be an accurate measure of 
physiological conditions. GSDMB gene is associated with various inflammatory disease 
phenotypes. The most prominent being inflammatory bowel disease, type-I diabetes 
and asthma (Halapi et al., 2010; Kang et al., 2012; Li et al., 2012; Mofatt et al., 2010; 
Wu et al., 2009). 
 
GSDMC 
Although GSDMC N-terminal fragment like other GSDM family proteins can form pores 
and induce pyroptosis on overexpression in 293Ts, GSDMC has not been reported to 
be cleaved by caspases in a physiological environment (Ding et al., 2016). Some 
studies have demonstrated its ability to serve as a transcription factor. It has a leucine 
zipper motif in its structure that suggests DNA binding ability (Watabe et al., 2001). 
 
GSDME/DFNA5 
GSDME is most widely studied for its association with hearing impairment in humans. 
Mutant GSDME protein resulting in a truncated C-terminus is strongly correlated with 
this phenotype. Contrary to other family members GSDME is cleaved by caspase-3, an 
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apoptotic effector caspase. On cleavage by caspase-3 GSDME can form pores in the 
plasma membrane and induce pyroptosis (Rogers et al., 2017; Wang et al., 2017). 
 
PJVK/DFNB59 
PVJK (DFNB59) similar to GSDME is associated with impaired cochlear responses in 
humans and mice. Mutations in PJVK can lead to nonsyndromic recessive deafness in 
human patients (Delmaghani et al., 2006; Delmaghani et al., 2015). 
 
 
E. c-GAS/STING Signaling 
 
Pathogen invasion and release of microbial DNA in the cytosol results in the activation 
of host DNA sensors in the cytosol. Another sensor that detects DNA in the cytosol 
along with AIM2 is cGAS. Apart from microbial DNA, self-DNA can also enter the 
cytoplasm under pathological conditions and in a tumor microenvironment. This can 
also be recognized by cytosolic DNA sensors such as cGAS. 
 
cGAS contains a DNA-binding domain and a catalytic nucleotidyltransferase domain 
(Sun et al., 2013). On binding DNA using its DNA-binding domain cGAS undergoes 
dimerization (Li et al., 2013 and Zhang et al., 2014). cGAS recognizes double stranded 
(ds) DNA in a sequence-independent manner (Sun et al., 2013). B-form of DNA can 
optimally bind cGAS as it has the ability to push an activation loop in the active site of 
cGAS resulting in its activation (Zhang et al., 2014). DNA binding to cGAS induced a 
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structural change that results in the synthesis of a secondary messenger cyclic GMP-
AMP (cGAMP), a dinucleotide from its substrates GTP and ATP (Sun et al., 2013, 
Zhang et al., 2014, Li et al., 2013 and Wu et al., 2013). 2’3’cGAMP binds to STING, an 
adaptor localized in the endoplasmic reticulum (ER) membrane and induces its 
dimerization (Ishikawa et al., 2008; Wu et al., 2013; Zhang et al., 2013; Zhong et al., 
2008). STING traffics from the ER to the golgi apparatus (Doobs et al., 2015; Ishikawa 
et al., 2009; Saitoh et al., 2009). STING activation and dimerization further results in 
auto-phosphorylation of the kinase TBK-1. TBK-1 phosphorylates IRF3 that 
subsequently dimerizes and enters the nucleus. IKK is also activated during STING 
signaling. IKK activation results in the release of NF-κB from inhibition. IRF3 and NF-κB 
are recruited to the nucleus where they result in the transcription of IFN-α/β and pro-
inflammatory cytokines such as tumor necrosis factor (TNF) and IL-6 respectively 
(Fitzgerald et al., 2003; Ishikawa et al., 2008; Sharma et al., 2003; Tanaka et al., 2012). 
 
F. Regulation of cGAS/STING Signaling 
 
Regulation of cGAS 
 
cGAS can be regulated by a variety of mechanisms prominent among them are 
regulation of cGAS through post-translational modifications. Glutamylation of cGAS is 
an important regulator of its catalytic activity. Glutamylases TTLL4 and TTLL6 are 
responsible for glutamylation of cGAS while deglutamylation enzymes CCP5and CCP6 
reverse the modification. Glutamylation of cGAS inhibits its activity. It has been 
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postulated that at steady state there is maintenance of homeostasis between 
glutamylated and deglutamylated cGAS (Xia et al., 2016). Akt can regulate cGAS 
activity by phosphorylation of a serine residue. Akt can phosphorylate Ser291 in mouse 
and Ser 305 in human cGAS.  
 
Recent evidences in literature have uncovered the cross-talk between inflammasome 
activation and type-I IFN production. Corrales et al., 2016 described what had been 
previously observed by various groups (Fernandes-Alnemri et al., 2010; Gray et al., 
2016; Hornung et al., 2009; Jones et al; 2010; Rathinam et al; 2010) that AIM2 
inflammasome regulates cGAS/STING mediated type-I IFN production. However, their 
study lacked the mechanistic insights of this process. Another study showed that 
caspase-1 when activated in DNA virus infection can cleave cGAS and thus regulates 
type-I IFN production (Wang et al., 2017). 
 
Regulation of STING 
 
Similar to cGAS post-translational modifications can also regulate STING. 
Phosphorylation of STING at Ser366 leads to the degradation of STING and 
suppression of type-I IFN production (Konno et al., 2013). Ubiquitination is another post-
translational modification capable of regulating STING. E3 ubiquitin ligase TRIM56 and 
TRIM32 are reported to enhance the Lys (K) 63 polyubiquitination of STING. Thereby, 
enhancing type-I IFN productin (Tuchida et al., 2010; Zhang et al., 2012). However, the 
role of ubiquitination is considered controversial. The E3 ligase complex containing 
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AMFR, GP78 and INSIG1 promote K63 ubiquitination and promote STING function 
(Wang et al., 2014). However, the E3 ligase complex containing RNF5 and TRIM30a 
promote K48 ubiquitination instead and target STING for degradation (Wang et al., 
2015; Zhong et al., 2014). 
 
cGAS-dependent type-I IFN production can also be regulated by influencing the stability 
and transport of the secondary messenger cGAMP. ENPP1, an enzyme present in the 
extracellular milieu has been reported to degrade cGAMP (Li et al., 2014).  
 
F.Type-I IFN Signaling 
 
Both human and murine type-I IFN family consists of 16 proteins; 12 IFN-α, IFN-β, IFN-
ε, IFN-κ, IFN-ω (McNab et al., 2015). Type-I IFNs can bind to the heterodimer receptor 
IFNAR-1 and IFNAR-2, thus initiating a downstream cascade of events. Binding to the 
IFNAR receptor leads to the phosphorylation and activation of Janus-associated kinase 
(JAK)-1 and tyrosine kinase (TYK)-2 (Plaintainas et al., 2005). Resulting in the 
phosphorylation of STAT1 and STAT2 that enables it to dimerize and recruit IRF9. 
STATI-STAT2-IRF9 complex then translocates to the nucleus where it binds to IFN 
response element (ISRE). To activate the transcription of IFN stimulated genes (ISGs) 
(Stark and Darnell Jr., 2012). Mitogen activated protein kinase (MAPKs) such as p38 
and ERK can also play a role in ISG expression (Platainias et al., 2005). ISGs affect a 
variety of cellular functions such as proliferation, differentiation, apoptosis and innate 
immune response to pathogens. 
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Heightened type I IFN response due to a failure of its regulatory mechanisms can lead 
to various chronic auto-immune and inflammatory diseases. Auto-immune diseases 
such as rheumatoid arthritis, systemic lupus erythematosus (SLE), Sjogen’s syndrome 
and Systemic sclerosis display the IFN signature (Hall and Rosen, 2010).  Type-I IFN is 
crucial for the pathogenesis of SLE. There is increased expression of ISGs in lupus 
patients (Kalliolas and Ivashikiv, 2010). IFN receptor (IFNAR) deficient mice displayed a 
lack of lupus-specific autoantibodies (Nacionales et al., 2007). Enhanced IFN-α 
production from plasmacytoid dendritic cells (DCs) of SLE patients further emphasized 
the role of type I IFN in SLE (Henault et al., 2016). 
 
 
H. Francisella Pathogenesis 
 
Francisella tularensis is a facultative intracellular gram-negative bacterium and the 
causative agent of tularemia. It primarily resides in macrophages although it has been 
shown to infect other myeloid cells such as dendritic cells and neutrophils and non-
immune cells such as alveolar epithelial cells and hepatocytes (Hall et al., 2007; Long et 
al., 1993; McCaffrey and Allen, 2006).  Francisella tularensis subsp. novicida, a murine 
pathogen has been extensively studied to investigate the mechanistic aspects of 
Francisella pathogenesis. F. novicida is taken up by macrophages in a phagosome. The 
phagosome initially fuses with the early endosome and then gets converted into the late 
endosome. At this stage on further acidification of the phagosomal compartment F. 
novicida escapes into the cytosol and replicates (Clemens et al., 2004, Santic et al., 
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2005). Bacterial virulence factors grouped into the Francisella pathogenicity island (FPI) 
locus are indispensible for the release of the pathogen into the cytoplasm (Nano et al., 
2004). FPI mutant F. novicida cannot escape the phagosome and is ultimately 
degraded by the fusion of the phagosome to the lysosome and is therefore not 
infectious (Bonquist et al.,2008, Brotcke et al., 2006 and Weiss et al., 2007). F. novicida 
can be detected by host defense sensors in the macrophages. LPS from F. novicida is 
structurally different from other gram-negative bacterial pathogens. Lipid A of F. 
novicida LPS is tetra-aceylated and is therefore not recognized by TLR4 that optimally 
recognizes hexa-aceylated LPS (Barker et al., 2006; Cole et al., 2006; Hajjar et al., 
2006; Raetz et al., 2009). F. novicida can however be recognized by TLR2 but only in 
an intranasal challenge (Collazo et al., 2006; Malik et al., 2006). 
 
I. Francisella recognition in the cytosol 
 
F. novicida escapes the phagosome and enters the cytoplasm, this makes it 
recognizable by the cytosolic host defense sensors thereby allowing the host to mount 
an immune response against the bug. The first indication of the cytosolic host response 
came from the study describing the role of IFN signaling in F. novicida infection (Henry 
et al., 2007). Thereafter it was thought that the IFN -inducible AIM2 plays a role in F. 
novicida recognition. In macrophages from AIM2 deficient mice there was an absence 
of inflammasome response to F. novicida demonstrating the role of AIM2 in 
inflammasome activation in response to F. novicida (Fernandes-Alnemri et al., 2010; 
Jones et al., 2010; Rathinam et al., 2010). AIM2 inflammasome activation is critical for 
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the host response to Francisella infection. AIM2 deficient mice have higher bacterial 
burdens and succumb to infection earlier than their wild type counterparts (Fernandes-
Alnemri et al., 2010; Jones et al., 2010). 
 
F. novicida is also recognized by other cytosolic host sensors. As previously mentioned 
F. novicida infection elicits a IFN response in macrophages (Henry et al., 2007). In 
subsequent studies, it was shown that stimulator of interferon genes (STING) is 
required for IFN response to F. novicida infection (Jin et al., 2011; Jones et al., 2010; 
Peng et al 2011). Type I IFN signaling in F. novicida infection drives the expression of 
IFN -inducible guanylate binding proteins (GBPs) especially GPB2 and GBP5 that are 
recruited to the bacterial surface. GBP2 and 5 are instrumental in bacterial lysis and 
release of DNA in the cytosol (Man et al., 2015 and Muenier et al., 2015). This bacterial 
DNA is then bound by the cytosolic DNA sensor AIM2 leading to inflammasome 
assembly and activation (Fernandes-Alnemri et al., 2010; Jones et al., 2010; Rathinam 
et al., 2010). GBP 2 and 5 are required to activate the AIM2 inflammasome and mice 
deficient in these proteins succumb to a Francisella challenge earlier than wild type 
mice (Man et al., 2015; Muenier et al., 2015). 
 
Since STING is required for IFN response to F. novicida infection (Jin et al., 2011, 
Jones et al., 2010; Peng et al 2011), the cytosolic DNA sensor that recognizes F. 
novicida DNA and elicits Type I IFN production could be cGAS. Storek et al 
subsequently found cGAS and Ifi204 to be cytosolic sensors of F. novicida DNA (Storek 
et al., 2011). 
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J. Francisella and Type I IFN 
 
The role of type-I IFN in bacterial infection varies depending on the nature of the 
bacterial pathogen. In Streptococcus infections type-I IFN plays a protective role 
(McNab et al., 2015). While in Mycobacterium tuberculosis, Listeria monocytogenes and 
F. novicida infections it is harmful for the host (Auerbuch et al., 2004, Henry et al., 2010, 
Mayer-Barber et al., 2014, McNab et al., 2015 and Storek et al., 2015). A recent study 
shows that although type-I IFN produced by cGAS/STING signaling has a crucial role in 
activating the AIM2 inflammasome (Man et al., 2017), it has an overall detrimental role 
in F. novicida infection. The authors show that IFN receptor Ifnar1 or Ifnar2 deficient and 
Ifnar2 AIM2 double deficient mice are more susceptible to F. novicida infection than 
their wild type counterparts. They further report increased apoptosis due to type-I IFN 
signaling in the liver in F. novicida infection. This may explain the detrimental role of IFN 
signaling as it has been previously demonstrated that hepatocytes have an essential 
role in F. novicida infection (Zhou et al., 2016 and Zhu et al., 2018). Some immune cell 
types such as γδ T cells may undergo less cell death in the absence of type-I IFN 
signaling and thereby they might secrete increased levels of protective IL-17 and IL-12 
in F. novicida infection (Zhu et al., 2018). 
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Chapter II 
Materials and Methods 
 
 
 
 
 
 
 
 
Results of the presented work have been published in Banerjee et al., 2018. 
A. Experimental Models 
 
 Mice C57BL/6J, Casp1/11-/-, AIM2-/-, Il1r-/-, and Il18r-/- mice obtained from the Jackson 
Laboratory (Bar Harbor, ME) were bred and maintained in specific pathogen–free 
conditions in the animal facilities of UConn Health. GSDMD-/- (Kayagaki et al., 2015), 
AIM2-/- (Jones et al., 2010), and caspase-11-/- mice (Kayagaki et al., 2011) obtained 
from Genentech (South San Francisco, CA) were also bred and maintained in specific 
pathogen–free conditions in the animal facilities of UConn Health. Asc-/- (Rathinam et 
al., 2010), Nlrp3-/- (Rathinam et al., 2012), cGas-/- (Suschak et al., 2016) mice were 
described previously. Both male and female mice of 8-24 weeks old were used. The 
animal protocols were carried out in accordance with the guidelines set forth by the 
UConn Health Institutional Animal Care and Use Committee.  
 
Differentiation of primary Bone-marrow Derived Macrophages  
 
Primary bone-marrow derived macrophages (BMDMs) were generated by culturing 
bone marrow cells from wild-type and various knockout mice in DMEM with 10% FBS 
and 20% L929 supernatants for 8 to 12 days. Cell culture media was replaced on day 3 
with fresh DMEM with 10% FBS and 20% L929 supernatants. Cells were harvested and 
used for experiments between days 7 and 12 of culture.  
 
Bacterial Strains  
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Bacteria and viruses used in this study include Francisella tularensis subsp. novicida 
strain Utah 112 (F. novicida; BEI resources, NIAID, NIH), Enterohemorrhagic E. coli 
(Vanaja et al., 2016), E. coli BL21 (Vanaja et al., 2016), and Sendai virus (Cantrell 
strain; Charles River Laboratories).  
 
B. Methods 
 
Cell stimulations and Infections  
 
F. novicida was grown over night at 37°C in Mueller Hinton broth. BMDMs and RAW 
macrophages were infected at an MOI of 50 or 100 (unless otherwise indicated) and 
after 1 – 2 h of infection, medium was replaced with gentamicin (100 mg/ml) containing 
medium. Cells were infected with Sendai virus (15 HA units/ml). Cells were transfected 
with lipofectamine 2000 (2 ml/ml) complexed poly(dA:dT) (1 µg/106 cells) or 2’-3’-
cGAMP (2.5 µg/106 cells) and stimulated with poly(I:C) (25 µg/ml), LPS (1 µg/ml). 
Supernatants were collected 6 h post-stimulations unless otherwise indicated. In certain 
experiments, cells were primed with 400 ng/ml Pam3CSK4 for 2–3 h before stimulations 
to assess inflammasome responses. The supernatants were collected 6–8 h post-
stimulation unless otherwise indicated. In some experiments, glycine (50 mM) was 
added to cells at the time of or 1 h after stimulations. In experiments where K+ efflux 
was inhibited, increasing concentrations of KCl was added to the medium at the time of 
stimulations. In experiments where K+ efflux was induced, cells were treated with 
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nigericin or valinomycin at the indicated concentrations 1.5-2 h after the stimulations or 
were incubated in K+ free medium throughout the duration of the experiment. Further, in 
some media replacement experiments, nigericin-containing media was replaced with 
DMEM without nigericin 1 h post addition of nigericin. Inhibition or induction of K+ Efflux 
using isosmotic media Isosmotic medium without or with defined concentrations of KCl 
was prepared as described previously (Rühl and Broz, 2015). Cells were infected with 
F. novicida and after 1 h of infection medium was replaced with gentamicin (100 mg/ml) 
containing buffer A (4.2 mM Na2CO3, 0.8 mM Na2HPO4, 1.3 mM CaCl2, 0.5 mM 
MgCl2, 10 mM D-glucose monohydrate, pH 7.4). For K+ efflux inhibition, cells were 
incubated in buffer A supplemented with 137 mM NaCl and 5 mM KCl, 117 mM NaCl 
and 25 mM KCl, or 92 mM NaCl and 50 mM KCl. For K+ efflux induction, cells were 
incubated in buffer A supplemented with 142 mM NaCl but without KCl. Cells were then 
stimulated and supernatants were collected as described above. Additionally, in some 
experiments 5 mM (iso-osmotic concentration) KCl was added to K+ free media 1 h post 
exposure to K+ free media.  
 
ELISA, Cell Death Assay, and Immunoblotting  
 
Levels of IFN-β and IL-18 in culture supernatants or plasma were assessed by ELISA 
as described before (Bossaller et al., 2012; Roberts et al., 2007). IFN-β levels are 
presented as units/ml or pg/ml depending upon the recombinant IFN-β standard used in 
the ELISA. IL-1β and IL-6 levels were assessed by Ready-Set-Go!® ELISA kits 
(eBioscience) according to the manufacturer’s instructions.  
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Cell death was assessed by LDH cytotoxicity detection kit (Clontech) unless otherwise 
indicated according to the manufacturer’s instructions. Intracellular ATP and metabolic 
activity was measured by using CellTiter-Glo assay (Promega) and PrestoBlue assay 
(Invitrogen), respectively, according to the manufacturer’s instructions.  
 
For western analysis, cells were lysed with 1% NP-40 lysis buffer. Samples were run on 
12.5% polyacrylamide gels and transferred onto nitrocelluose membranes by using 
Trans-Blot Turbo Transfer System (Bio-Rad). Blots were then blocked and probed with 
appropriate primary and secondary antibodies, and proteins bands were visualized with 
Bio-Rad Clarity ECL HRP substrate on a Syngene gel documentation box.  
 
Liquid Chromatography-Mass Spectrometric measurement of cGAMP  
 
Cells were stimulated with F. novicida or poly(dA:dT) for 5 h and snap-frozen. Cell 
extract prepared with methanol was filtered with 30 kDa filter to remove debris, dried, 
resuspended in water. c-di-AMP was added to the samples as an internal control. 
Samples were transferred to vials, capped and placed into the autosampler (kept at 4 
°C). Aliquots of 10 or 20 µl from each vial was injected, along with cGAMP standards, 
onto the LC–MS/MS system (Agilent 1200 Autosampler and Binary pump 20 
(Wilmington, DE, USA) coupled to an ABI4000Q bench top mass spectrometer (MDS 
SCIEX, Concord, ON, Canada). The MRM m/z transitions monitored for cGAMP and c-
di-AMP were 675.5>506.0, and 659.0>524.0, respectively. Data was collected with the 
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Analyst software.  
 
Intracellular Potassium Measurement  
 
Wild-type, GSDMD-/-, caspase-1/11-/-, and AIM2-/- cells plated in 96-well clear bottom 
black plates were stimulated with F. novicida in glycine (50 mM)-containing media. After 
6 h of stimulation, medium was replaced with PBS containing asante potassium green 
(APG)4 for 1 h, which is extremely specific for K+ (Eil et al., 2016; Prindle et al., 2015), 
and pluronic acid F-127, which aids in efficient permeation of APG4 into the cells. After 
1 h of incubation at 37°C, cells were washed with PBS and the fluorescence was read 
with ClarioStar multimode microplate reader (BMG LABTECH, Germany).  
 
Reconstitution of GSDMD-/- iBMDMs with GSDMD  
 
HEK293T cells were transfected with pMSCV-puro (empty vector; EV), pMSCV-puro 
encoding 2xFLAG-HA-GSDMD, or pMSCV-puro encoding 2xFLAG-HA-I105N GSDMD 
mutant and retro viral packaging plasmids. Viral supernatants collected after 48 and 72 
h of transfection were concentrated by centrifugation at 20,000 x g for 2 h and used to 
transduce GSDMD-/- iBMDMs. Transduced cells were selected using puromycin, and 
the expression of wild-type and mutant GSDMD was verified by western blotting with 
FLAG and GSDMD antibodies.  
 
Mice Infections  
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F. novicida was grown over night at 37°C in Mueller Hinton broth. C57BL/6 (wild-type; 
WT), AIM2-deficient (Rathinam et al., 2010), caspase-1/11-/-, and GSDMD-/- mice were 
subcutaneously infected with 1.5 or 5 Å~ 105 CFU of F. novicida. Cytokine levels in the 
plasma were analyzed at 24 h post-infection. C57BL/6 (wild-type; WT) and AIM2-/- mice 
were infected with 1 Å~ 109 CFU of E. coli BL21 by i.p. injection. Cytokine levels in the 
plasma were analyzed at 6 h post-infection. Mice were infected with 2.5 Å~ 102 CFU of 
F. novicida in the survival studies. In some survival experiments, WT and AIM2-/- mice 
were injected i.p. with 250 mg of an isotype control or anti-IFNAR antibody (clone: 
MAR1-5A3) 12 h p.i.  
 
cGAS-DNA binding assay  
 
Wild-type and GSDMD-/- BMDMs were stimulated with F. novicida. After 6 h post 
stimulation, media was replaced with PBS containing 1% paraformaldehyde (PFA), and 
the cells were incubated for 10 min at room temperature. The crosslinking reaction was 
then quenched with 0.1 M Tris pH 7.4 in PBS. The cells were the collected and lysed in 
0.5%Triton-X 100 lysis buffer. cGAS immunoprecipitation was performed by adding 
protein A beads and anti- cGAS antibody to the lysates After overnight incubation at 4 
C, beads were washed twice with low salt, high salt, and lysis buffers. Then 
antibody/protein/DNA complexes were eluted with a freshly prepared elution buffer (1% 
SDS/0.1 M NaHCO3 pH 8.0) Beads mixed with elution buffer was shaken on vortex for 
15 min and then centrifuged at 13,000 rpm for 3 min. Eluted samples were then de-
crosslinked by adding 0.3 M sodium chloride and incubating at 65 C for 4h. This was 
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followed by protein digestion using proteinase K at 45 C for 2 h. DNA was finally purified 
using phenol/chloroform/isoamyl alcohol precipitation. F. novicida DNA bound to cGAS 
was quantified by real time PCR with primers targeting bacterial genome (mglA), The 
PCR products were also run on a 1.5% agarose gel and imaged under UV light using a 
Syngene gel documentation box.  
 
cGAS Immunofluorescence Staining  
 
Wild-type and GSDMD-/- BMDMs were infected with F. novicida or transfected 
poly(dA:dT). After 5 h, the cells were washed with PBS, fixed with 4% 
paraformaldehyde, permeabilized with 0.1% Triton-X, blocked with 10% goat serum, 
incubated overnight at 4 oC with anti-cGAS antibody, and stained for 1 h with 
fluorescently labeled anti-rabbit secondary antibody. Plasma membrane and 
nucleus/DNA were stained with cholera toxin B Alexa fluor 647 conjugate (CTB) (Life 
Technologies) and DAPI, respectively. The cells were visualized using a Zeiss LSM 780 
microscope.  
 
In vitro cGAS Enzymatic Assay  
 
Recombinant mouse cGAS (catalytic domain) (28 ng) was mixed in a 10 ml reaction 
buffer (20 mM Tris-Cl [pH 7.4], 5 mM MgAc) with 10 or 2 ng DNA (100 base pair), 12 
mM each ATP and GTP, and 5.0 mCi of a-32P-ATP (800Ci/mmol). After 120 min of 
incubation at 37 °C, the reaction mixture was heated to 65 °C for 5 min, treated with 
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calf-intestinal alkaline phosphatase, and analyzed by thin layer chromatography (TLC) 
as described before (Kranzusch et al., 2013).  
 
Flow Cytometry  
 
For flow cytometric quantification of viperin expression, cells were stimulated with F. 
novicida, poly(dA:dT), or IFN-β (500 IU/ml) for 16 h. Cells were fixed in 4% 
paraformaldehyde and permeabilized with 0.1% saponin in PBS and stained with anti-
viperin antibody in FACS buffer (PBS with 3%FBS and 0.1% sodium azide). Samples 
were run on LSR-II (BD Biosciences) and analyzed using FlowJo software.  
 
Quantification and Statistical Analysis  
 
Data were analyzed for statistical significance by two-way ANOVA followed by the 
Sidak’s post- test, unpaired two-tailed t test, or Mantel-Cox test as indicated with Prism 
Software. *, P <0.05; ns, not significant. 
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Chapter III 
Results 
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Results of the presented work have been published in Banerjee et al., 2018. 
 
A. AIM2 inflammasome inhibits IFN-β response to cytosolic DNA in 
vitro and in vivo 
 
F. novicida is a cytosolic pathogen that robustly activates IFN-β response via its DNA 
(Fernandes-Alnemri et al., 2010; Jones et al., 2010; Man et al., 2015a; Meunier et al., 
2015; Rathinam et al., 2010; Storek et al., 2015) and thus represents a valuable model 
system to investigate cGAS regulatory mechanisms in bacterial infections. F. novicida 
also stimulates another cytosolic DNA receptor, AIM2  (Fernandes-Alnemri et al., 2009; 
Hornung et al., 2009; Jones et al., 2010; Man et al., 2015a; Meunier et al., 2015; 
Rathinam et al., 2010). In contrast to cGAS that induces transcriptional induction of the 
type I IFN, AIM2, upon directly binding DNA in the cytosol, forms an inflammasome 
complex by oligomerizing ASC and caspase-1. Infection with F. novicida or transfection 
of the synthetic double stranded DNA mimetic, poly(dA:dT), into the cytosol induced IL-
1β secretion in wild-type bone marrow derived macrophages (BMDMs), and this 
response was abolished in AIM2-/- BMDMs (Fig. 1A). In stark contrast, AIM2-/- BMDMs 
secreted higher levels of IFN-β than wild- type BMDMs in response to F. novicida (Fig. 
1B). Similarly, poly(dA:dT)-induced IFN-β secretion was elevated in AIM2-/- BMDMs 
compared to wild-type BMDMs consistent with the earlier observations (Fig. 1B) 
(Corrales et al., 2016; Fernandes-Alnemri et al., 2010; Gray et al., 2016; Hornung et al., 
2009; Jones et al., 2010; Rathinam et al., 2010). In line with their enhanced production 
of IFN-β, F. novicida- and poly(dA:dT)-stimulated AIM2-/- BMDMs, compared to wild-
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type BMDMs, expressed higher levels of IFN stimulated gene (ISG) products such as 
viperin and ISG15 (Fig. 1C). AIM2 has been shown to inhibit colon tumorigenesis 
independently of the inflammasome complex (Man et al., 2015b; Wilson et al., 2015). To 
test if the IFN-suppressive role of AIM2 is inflammasome-dependent or - independent, 
we used Asc-/- and caspase-1/11-/- macrophages. ASC-, and caspase-1/11- deficient 
BMDMs phenocopied AIM2-deficient BMDMs and produced more IFN-β after 
poly(dA:dT) transfection or F. novicida infection (Fig. 1D and 1E). Moreover, unlike 
poly(dA:dT) and F. novicida, TLR ligands (LPS and poly(I:C)) and RNA virus (Sendai) 
that do not engage the AIM2 inflammasome induced normal levels of IFN-β production 
in AIM2-/-, Asc-/-, or caspase- 1/11-/- BMDMs (Fig. 1D-F). Taken together, these data 
clearly demonstrate that AIM2-mediated inhibition of IFN- β is dependent on its 
inflammasome-activating ability (Corrales et al., 2016; Wang et al., 2017). We examined 
if AIM2 exhibits a similar suppressive effect on cGAS-induced IFN-β response to 
cytosolic DNA during bacterial infections in vivo. Towards this end, we utilized the F. 
novicida infection model as F. novicida stimulates both cGAS-STING-IFN-β and AIM2 
inflammasome pathways in mice (Fernandes-Alnemri et al., 2010; Jones et al., 2010; 
Man et al., 2015a; Meunier et al., 2015; Rathinam et al., 2010; Storek et al., 2015). In 
line with the in vitro results in macrophages, plasma IFN-β levels at 24 h p.i were 
significantly higher in F. novicida- infected mice lacking AIM2 than in infected wild-type 
mice (Fig. 1G). On the other hand, wild- type mice had increased levels of IL-1β in 
plasma compared to AIM2-/- mice (Fig. 1H). We further tested the involvement of the 
inflammasome complex in AIM2 suppression of cGAS signaling by monitoring F. 
novicida-induced IFN- β production in caspase-1/11-/- mice. Similar to our observations 
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in AIM2-/- mice, caspase-1/11-/- mice had significantly elevated levels of IFN-β but 
reduced levels of IL-18 in plasma relative to wild-type mice (Fig. 1I and 1J). 
Furthermore, E. coli, which engages the caspase-11-noncanonical inflammasome but 
not the AIM2 inflammasome (Kailasan Vanaja et al., 2014; Rathinam et al., 2012), 
induced comparable levels of IFN-β production in wild-type and AIM2-/- mice (Fig. 1K). 
Thus, it is evident from all these data that the AIM2 inflammasome functions to limit 
cytosolic DNA-induced type I IFN responses in-vivo. 
 
 
B. AIM2 restricts cytosolic DNA-driven type I IFN responses via 
GSDMD 
 
GSDMD is a newly identified substrate for inflammasome-activated caspase-1 (He et 
al., 2015; Kayagaki et al., 2015; Shi et al., 2015). This raises two possibilities by which 
the AIM2 inflammasome may exert its regulatory effect on IFN-β production; first, 
caspase-1 activated by AIM2 may directly regulate cGAS-induced IFN-β production 
without involving GSDMD. Consistent with this possibility, a recent study showed that, 
during viral infections, caspase-1 depletes cellular levels of full length cGAS by cleaving 
it and thus inhibiting type I IFN production (Wang et al., 2017). However, in our study, 
strong caspase-1 activation by AIM2 inflammasome ligands, F. novicida and 
poly(dA:dT), and NLRP3 stimuli, nigericin and ATP, in wild-type BMDMs did not result in 
any reduction in cGAS protein levels or its cleavage (Fig. 2A). An alternative possibility 
is that GSDMD activated by the AIM2 inflammasome (Fig. S1A) (Kayagaki et al., 2015; 
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Shi et al., 2015) might mediate the suppression of IFN-β. To test this, we examined 
poly(dA:dT)- and F. novicida-induced IFN-β secretion in wild-type and GSDMD-/- 
immortalized BMDMs (iBMDMs). We found that, while IL-1β secretion and cell death 
were reduced, IFN-β production was markedly higher in GSDMD-/- cells, phenocopying 
AIM2-/- cells (Fig. 2B-D). The augmented production of IFN-β in response to cytosolic 
DNA was also observed in primary BMDMs from GSDMD-/- mice (Fig. S1B). 
Furthermore, the kinetic analysis showed sustained hyper-production of IFN-β by F. 
novicida- infected GSDMD-/- BMDMs over a period of time (Fig. 2E). In this time course 
analysis, GSDMD-/- BMDMs displayed, as expected, reduced LDH release upon F. 
novicida infection. However, there was no difference in the intracellular ATP levels of F. 
novicida-infected wild-type and GSDMD-/- BMDMs (Fig. 2F). In other words, an increase 
in cytosolic DNA-induced IFN- β production was evident in GSDMD-/- BMDMs without a 
concomitant increase in intracellular ATP levels. E. coli induces IFN-β via TLR4 
(Kailasan Vanaja et al., 2014; Rathinam et al., 2012) and elicits GSDMD activation and 
cell death via caspase-11 (Fig. 2G) (Kayagaki et al., 2015). E. coli triggered comparable 
levels of IFN-β production in wild-type, GSDMD-/- and caspase-11-/- macrophages, 
indicating that the TLR4-driven IFN-β production is not sensitive to GSDMD-mediated 
inhibition (Fig. 2G). Sendai virus-induced IFN-β was also comparable between wild-type 
and GSDMD-/- cells (Fig. 2H). Like IFN-β, cGAS- dependent production of IL-6 was also 
higher in F. novicida-infected GSDMD-/- macrophages (Fig. 2I-K). IFN-β production per 
cell was measured by intracellular staining followed by flow cytometry for viperin, as a 
surrogate for IFN-β. This revealed that viperin expression on a per-cell basis as 
indicated by the mean fluorescence intensity was higher in F. novicida- or poly(dA:dT)-, 
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but not IFN-β-, stimulated GSDMD-deficient cells compared to wild-type cells (Fig. 
S1C). Unlike GSDMD-/- BMDMs, Nlrp3-/- BMDMs produced IFN-β at a level comparable 
to wild-type BMDMs upon F. novicida infection (Fig. S1D). These results 
suggest that the AIM2 inflammasome down-regulates type I IFN responses via GSDMD. 
To test the role of GSDMD in type I IFN response to F. novicida infection in vivo, wild-
type and GSDMD-/- mice were infected with F. novicida, and plasma IFN-β was 
measured at 24 h p.i. Similar to our observations in vitro in BMDMs, GSDMD-deficient 
mice had significantly elevated levels of IFN-β in plasma relative to wild-type mice (Fig. 
2L). However, the bacterial loads in the spleens and livers of wild-type and GSDMD-/- 
mice were similar suggesting that the increased IFN-β in GSDMD-/- mice was not due to 
higher bacterial burden (Fig. 2M). Wild-type and GSDMD-/- mice were infected with F. 
novicida and monitored for survival to address the role of GSDMD in host defense. 
Notably, GSDMD deficiency compromised the survival of the host as GSDMD-deficient 
mice succumbed to F. novicida infection earlier than WT mice (Fig. 2N). Next, we 
sought to understand if the elevated IFN-β levels in inflammasome-deficient mice 
impact host resistance to F. novicida. To this end, type I IFN signaling in F. novicida-
infected AIM2-/- mice was partially blocked with the administration of very low dose of 
anti-IFNAR antibody (250 mg/mouse) just once (12 h p.i.), and the survival of mice was 
monitored. Strikingly, anti-IFNAR antibody-treated AIM2-/- mice survived significantly 
longer than AIM2-/- mice treated with an isotype control antibody (Fig. 2O). In fact, the 
survival of AIM2-/- mice was rescued to wild-type levels by the anti-IFNAR antibody. This 
data suggest that the elevated IFN-β in the absence of AIM2 and GSDMD increases the 
susceptibility of the host to F. novicida infection. Consistent with our result with anti-
 35 
IFNAR antibody, a latest report showed that the genetic deletion of IFNAR1 in AIM2-
deficient mice protected AIM2-/- mice from F. novicida infection (Zhu et al., 2018). 
Overall, GSDMD activated by the AIM2 inflammasome reins in the host-detrimental type 
I IFN expression, promoting anti-bacterial defense. 
 
C. GSDMD targets cGAS to suppress cytosolic DNA-induced IFN-β 
production. 
 
Upon binding DNA, cGAS catalyzes the synthesis of a second messenger molecule, 
cGAMP, from ATP and GTP. cGAMP binds to its receptor, STING, and the dimerized 
STING triggers the activation and self-phosphorylation of TBK1, which in turn 
phosphorylates IRF3 to initiate IFN-β transcription (Sun et al., 2013). To define which 
step of this pathway is affected by GSDMD, we examined the above-described events 
in cGAS signaling in wild-type and GSDMD-/- macrophages. F. novicida and 
poly(dA:dT), but not LPS and Sendai virus, induced phosphorylation of TBK1 and IRF3 
was substantially higher in GSDMD-/- (Fig. 3A) and AIM2-/- (Fig. 3B) macrophages 
compared to wild-type cells. These results indicate that the upstream cGAS or STING 
activation itself is likely to be affected by GSDMD. To explore this, cGAS binding of 
DNA was assessed by immunoprecipitation of cGAS from F. novicida- infected BMDMs 
followed by PCR analysis of bacterial DNA bound to cGAS. This approach revealed that 
cGAS in GSDMD-/- BMDMs bound to significantly higher quantity of F. novicida DNA 
than cGAS in wild-type BMDMs suggesting that GSDMD affects cGAS binding of DNA 
(Fig. 3C-D).  Detection of STING dimerization using non-reducing PAGE showed 
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elevated levels of STING dimers in F. novicida- and poly(dA:dT)-, but not cGAMP- 
stimulated gasdermin-D-/- cells (Fig. 3K), which is in concordance with the higher cGAS 
activation in the absence of GSDMD. Taken together, these data suggest that GSDMD 
targets cGAS to suppress cytosolic DNA-induced IFN-β production. 
 
 
D. GSDMD suppresses cGAS-dependent type I IFN response by 
triggering potassium (K+) efflux.  
 
We next sought to define the mechanism involved in the cGAS-suppressive function of 
GSDMD. Whereas the formation of plasma membrane pores and the cessation of 
metabolic activity during pyroptosis are not sensitive to glycine, the swelling and 
terminal rupture of cells is delayed by glycine (Conos et al., 2017; Evavold et al., 2018; 
Russo et al., 2016). In agreement with the previous reports (Conos et al., 2017; Evavold 
et al., 2018; Fink et al., 2008; Moltke et al., 2012; Rühl and Broz, 2015), glycine greatly 
reduced F. novicida-induced pyroptotic lysis as assessed via LDH release (Fig. 4A) or 
Cell-Tox Flo assay (Fig. 4B). More relevantly, glycine-treated cells, which were resistant 
to GSDMD-induced lysis, did not produce excessive amounts of IFN-β in response to F. 
novicida (Fig. 4C). The AIM2 inflammasome catalyzes the maturation of IL-1β and IL-18 
via caspase-1 and mediates their release in a GSDMD-dependent manner. Therefore, it 
is possible that active IL-1β and/or IL-18 can act in an autocrine or paracrine fashion to 
control the type I IFN responses as shown in the case of M. tuberculosis infection 
(Mayer-Barber et al., 2014). To test this idea, we compared F. novicida-induced IFN-β 
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production in IL-1R- and IL-18R-deficient BMDMs with that of wild-type BMDMs. In 
contrast to the phenotype in AIM2- and GSDMD-deficient cells, IFN- β response in IL-
1R- and IL-18R-deficient BMDMs was comparable to that of wild-type BMDMs (Fig. 4D). 
Furthermore, to address if there is any redundancy between IL-1β and IL-18 in 
regulating IFN-β, IL-1β signaling in IL-18r-/- BMDMs was blocked with IL-1R antagonist, 
and IFN-  response to cytosolic DNA was tested. As shown in Fig. 4E, the inhibition of 
IL-1R signaling with IL-1R antagonist did not affect F. novicida-induced IFN-β secretion 
in IL-18r-/- and WT BMDMs, thus ruling out a role for IL-1β and IL-18 in GSDMD control 
of IFN-β. The N terminal fragment of GSDMD binds to plasma membrane phospholipids 
forming pores with an inner diameter of 10 – 15 nm (Aglietti et al., 2016; Ding et al., 
2016; Liu et al., 2016; Sborgi et al., 2016). These pores permit ionic fluxes across the 
plasma membrane dissipating intracellular ionic gradients. It is well documented that the 
formation of GSDMD- pores triggering ionic fluxes is an early event in the cell lytic 
cascade and is succeeded by water influx, rise in osmotic pressure, cell swelling, the 
extensive loss of membrane integrity, and eventual lysis (Bergsbaken et al., 2009; 
Evavold et al., 2018; Fink and Cookson, 2005). Thus, GSDMD-mediated ion fluxes and 
the pyroptotic cell death are kinetically separable events (Evavold et al., 2018; 
Katsnelson et al., 2015; Moltke et al., 2012; Russo et al., 2016). Recent reports show 
that ionic perturbations induced by pore forming proteins govern cellular functions. For 
instance, ionic fluxes driven by mixed lineage kinase-like (MLKL), the pore forming 
effector of the necroptotic pathway, has been shown to facilitate plasma membrane 
repair as well as activate NLRP3 inflammasome prior to cell death (Conos et al., 2017; 
Gong et al., 2017; Gutierrez et al., 2017). Taking all this into consideration, we reasoned 
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that GSDMD- mediated ionic fluxes—particularly the efflux of potassium (K+), which is 
the most abundant ion in the intracellular milieu with a steep gradient across the plasma 
membrane—may play a role in the negative regulation of cGAS-dependent type I IFN 
responses. First, we assessed if inflammasome-mediated GSDMD activation during F. 
novicida infection triggers potassium efflux by utilizing a highly specific potassium stain, 
APG4 (Eil et al., 2016; Prindle et al., 2015). We observed that the intracellular levels of 
K+ dropped significantly following infection with F. novicida in wild-type macrophages 
but not in macrophages lacking AIM2, caspase-1/11, or GSDMD (Fig. 4F-H). The 
reductions in intracellular levels of K+ in wild-type cells was not due to cell lysis as these 
experiments were performed in the presence of glycine, which prevented cell lysis but 
not K+ efflux (Fig. S2A). Next to assess if potassium efflux is required for the GSDMD-
mediated suppression of IFN responses, K+ efflux was diminished by increasing the 
extracellular concentration of K+ with KCl (Muñoz-Planillo et al., 2013) and its effect on 
IFN-β secretion was tested. Remarkably, the incubation of wild-type macrophages in 
DMEM or isosmotic minimal medium supplemented with increasing concentrations of 
KCl to block K+ efflux increased poly(dA:dT)- induced IFN-β secretion without affecting 
pyroptosis or cell viability (Fig. 4I and 4J). The blockade of K+ efflux similarly enhanced 
IFN-b secretion following F. novicida infection without affecting pyroptosis or cell viability 
(Fig. 4K and 4L). These results clearly indicate that GSDMD attenuates cGAS-induced 
type I IFN s by inducing K+ efflux. An isoleucine-to- asparagine mutation at position 105 
(I105N) in the N terminus of GSDMD compromises its capacity to efficiently oligomerize, 
form pores and presumably induce ionic flux (Aglietti et al., 2016). This evidence 
supports a role for GSDMD-driven pores and ionic flux in the inhibition of cGAS 
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signaling. 
 
 
E. K+ efflux is sufficient to inhibit type I IFN response to cytosolic DNA. 
 
If GSDMD activation dampens IFN-β production in wild-type BMDMs via K+ efflux as we 
hypothesize, then pharmacologically restoring K+ efflux in inflammasome- and GSDMD- 
deficient cells would reinstate this inhibition and reduce cytosolic DNA-induced type I 
IFN response back to wild-type levels. We tested this idea by utilizing two well-
characterized K+ ionophores, nigericin and valinomycin (Page and Di Cera, 2006). RAW 
cells were used in these experiments as they lack ASC and therefore, are resistant to 
inflammasome-mediated pyroptosis following nigericin and valinomycin stimulation (Fig. 
S3A). Nigericin and valinomycin induced K+ efflux in RAW macrophages as assessed 
by APG4 staining (Fig. 5A and 5B). Consistent with its induction of K+ efflux, nigericin 
suppressed IFN-β production by RAW cells following F. novicida infection and 
poly(dA:dT) transfection (Fig. 5A and 5C). But nigericin did not inhibit TLR-mediated 
IFN-β response to LPS and poly(I:C) (Fig. 5C). This result suggest that the suppressive 
effect of nigericin on F. novicida- and poly(dA:dT)-induced IFN-β production is neither 
due to global shut down of IFN-β expression nor cytotoxicity. Similar to nigericin, 
valinomycin impaired RAW cell production of IFN-β following F. novicida and 
poly(dA:dT) stimulations (Fig. 5B). Unlike these K+ ionophores, the calcium ionophore, 
ionomycin, did not affect F. novicida-induced IFN-β secretion (Fig. S3B). Similarly, the 
calcium chelator, BAPTA- AM, had no effect on IFN-β response to cytosolic DNA (Fig. 
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S3C). These results, thus, rule out a role for calcium influx in type I IFN inhibition by 
GSDMD. Nigericin treatment reduced cGAMP levels in F. novicida- and poly(dA:dT)-
stimulated RAW cells, supporting the notion that GSDMD targets cGAS via K+ efflux 
(Fig. 5D). In agreement with the impairment of cGAS activation by K+ efflux, nigericin 
reduced TBK1 and IRF3 activation in RAW macrophages in response to poly(dA:dT) but 
not LPS (Fig. 5E). These results indicate that K+ efflux targets the cytosolic cGAS-
STING-mediated IFN-β response but not TLR-initiated type I IFN responses. Next, we 
used caspase-1/11-/- macrophages to validate these findings. Compared to F. novicida-
infected wild-type cells, caspase-1/11-/- BMDMs had higher levels of intracellular K+ and 
secreted increased levels of IFN-β (Fig. 5F and 5G). Addition of nigericin or valinomycin 
to caspase-1/11-/- BMDMs lowered intracellular K+ content and correspondingly reduced 
IFN-β production (Fig. 5F and 5G). Importantly, this IFN-β reduction upon nigericin and 
valinomycin treatments was not due to cell death as the caspase-1/11 deficiency and 
the use of very low amounts of nigericin and valinomycin circumvented nigericin- and 
valinomycin-induced cell death (Fig. S3D). It should also be noted that while cytosolic 
DNA-induced IFN-β secretion by caspase-1/11-/- BMDMs was tremendously diminished 
by nigericin or valinomycin, LPS- and poly(I:C)-induced IFN-β secretion remained 
unaffected (Fig. 5H). Similarly, the incubation of caspase-1/11-/- macrophages in K+ free 
medium, which is known to trigger K+ efflux (Rühl and Broz, 2015), diminished their 
higher IFN-β production, in response to F. novicida and poly(dA:dT), to levels 
comparable to that of wild-type cells (Fig. 5I). On the other hand, poly(I:C)-induced IFN-
β production was not affected by the potassium levels of the medium (Fig. 5I). The 
increased IFN-β secretion by F. novicida-infected GSDMD-deficient macrophages was 
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also reduced to wild-type levels by nigericin and valinomycin without affecting cell death 
(Fig. 5J, 5K, and S3D). In contrast, IFN-β production by GSDMD- deficient 
macrophages in response to TLR4 and TLR3 activation was not suppressed by 
nigericin and valinomycin (Fig. 5L). Furthermore, detailed dose response experiments in 
WT, GSDMD-/-, caspase-1/11-/-, and RAW macrophages showed that extremely low 
concentrations of nigericin (20-50 nM) are able to inhibit F. novicida- and poly(dA:dT)-
induced IFN-β response without affecting cell viability and metabolic activity as indicated 
by CellTiter-Glo and PrestoBlue assays (Fig. 5M-O and S4A-C). Minimal concentrations 
of valinomycin (50-100 nM) also decreased IFN-β response to cytosolic DNA without 
reducing cell viability and metabolic activity (Fig. S4D). More importantly, K+ free media-
induced reduction in IFN-β production was reversed when KCl was returned to culture 
medium (Fig. 5P) indicating that the cells remained viable during exposure to K+ free 
media. Likewise, nigericin-induced reduction in IFN-β production was reversed when the 
K+ ionophore was replaced from culture medium (Fig. S4E). Altogether, the striking 
effects of K+ efflux blockade and K+ efflux induction by pharmacological (K+ ionophores) 
and non-pharmacological (K+ free medium) means on IFN-β production in multiple cell 
types provide substantial evidence that K+ efflux is necessary and sufficient to inhibit 
cytosolic DNA-induced type I IFN response. The data reinforces that K+ ion is critical for 
cGAS catalytic activity and the depletion of its intracellular levels by GSDMD pores 
impairs cGAS function independent of cell death. 
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Chapter IV 
Discussion 
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Gasdermin-D suppresses cytosolic DNA-induced type-I IFN 
production by inducing K+ efflux. 
 
The c-GAS DNA sensor is an important pathway in the host cell for mounting an 
immune response to cytosolic pathogens. cGAS senses pathogen DNA and also host 
cell DNA that leaks into the cytosol during some pathological condition. It signals 
through the adapter STING, kinase TBK-1 and transcription factor IRF3 that induces the 
production of type-I IFN (Sun et al., 2013). Although type–I IFN has a beneficial role in 
viral and some bacterial infections, its excessive signaling is detrimental in some 
intracellular bacterial infections and can result in pathology in autoimmune and 
inflammatory diseases. 
 
The release DNA in the cytosol of macrophages is recognized by sensors cGAS and 
AIM2 in macrophages. In contrast to cGAS, AIM2 sensing of DNA leads to the 
assembly and the activation of the inflammasome complex (Hornung and Latz, 2010). 
Our findings show that similar to prior reports in literature; cytosolic DNA induced 
activation of the inflammasome complex suppressed the production of type-I IFN 
production both in-vitro and in-vivo (Fig. 1; Corrales et al., 2016; Fernandes-Alnemri et 
al., 2010; Gray et al., 2016; Hornung et al., 2009; Jones et al., 2010; Rathinam et al., 
2010; Wang et al., 2010). Inflammasome activation in turn leads to the cleavage and 
activation of GSDMD. We further showed that similar to mice deficient in inflammasome 
components (AIM2-/- and caspase-1/11-/-) GSDMD-/- also show increased type-I IFN 
production. GSDMD deficient animals are more susceptible to F. novicida infection due 
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to the detrimental effects of heightened type-I IFN produced in these animals (Fig.2). 
GSDMD is cleaved into its N- and C-terminus domains. N-terminus of GSDMD 
oligomerizes and forms pores in the plasma membrane.  These non-selective pores 
formed by GSDMD leads to the exchange of fluids and ions. The exchange of ions 
through a non-selective pore depends on the ion gradient across the cell membrane. K+ 
has a high concentration in the cytosol compared to the extracellular fluid. Therefore, 
formation of GSDMD pores leads to K+ efflux (Aglietti et al., 2016; Ding et al., 2016; 
Kovacs and Miao, 2017; Liu et al., 2016; Sborgi et al., 2016). This study reports that the 
depletion of intracellular K+ from the cell inhibits cGAS detection of DNA. Thereby, 
restraining cytosolic DNA-induced type-I IFN production (Fig 3, 4,5). 
 
Many recent studies have attempted to separate the established role of GSDMD in cell 
death from new roles in a variety of cellular functions. Inflammasome activation results 
in the secretion of IL-1β and IL-18. These two IL-1 family members, similar to rest of the 
cytokines of the group lack the signal peptide for conventional protein secretion through 
the ER and golgi apparatus. These cytokines are released from the cell using an 
alternative secretory pathway.  
Recent reports have shown that this release is dependent on GSDMD. Evavold et al., 
using stimuli that do not cause pyroptosis but results in the cleavage of GSDMD have 
demonstrated that IL-1β is released from non-pyroptotic cells in a GSDMD dependent 
manner (Evavold et al., 2018). GSDMD has also been reported to be essential for the 
formation of NETs from neutrophils in extracellular bacterial infections independent of 
pyroptosis (Chen et al., 2018; Sollberger et al., 2018). Further, consolidating the 
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evidence that GSDMD is essential for cellular functions not restricted to pyroptosis. 
 
This study provides multiple lines of evidence showing that regulation of type-I IFN 
production by GSDMD can be separated from its role in pyroptosis 
 
1. Inhibiting K+ efflux by neutralizing the extracellular ionic gradient by adding KCl to 
the extracellular media increases the IFN level without any change in cell death. 
2. Inducing K+ efflux in inflammasome and GSDMD deficient cells using chemical 
agents such as nigericin that acts as K+ ionophore in inflammasome deficient 
cells and at very low doses does not affect the viability of the cell. 
3. K+-free media and K+ ionophore mediated inhibition was reversible. 
4. In a cell free system, K+ concentration can regulate the amount of cGAMP 
production by cGAS. 
 
The kinetics of these events dictate whether GSDMD can impact other functions in the 
cell. 
The formation of GSDMD pores in the plasma membrane disrupts the normal 
concentration of ions across the plasma membrane. K+ has a high concentration in the 
cytoplasm and a low concentration in the extracellular milieu therefore disruption of the 
plasma membrane barrier by formation of GSDMD pores leads to the efflux of K+ ions. 
Sodium (Na) has the reverse gradient. There is an influx of Na+ in the cell that is 
accompanied by water resulting in cell swelling (Kovacs and Miao, 2017). The GSDMD 
pore is 10-15 nm in diameter and therefore K+ that are 0.2 nm or mature forms of IL-1β 
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or IL-18 that are 4.5 and 5 nm in diameter respectively can pass through the GSDMD 
pores but cell organelles that are larger than 15 nm cannot leak out, thereby maintaining 
cell integrity (Ding et al., 2016; Liu et al., 2016). The concentration of cleaved GSDMD 
and thereby, the number of pores formed in the cell membrane is a determinant of 
whether the cell will undergo pyroptosis. Therefore, repair mechanisms can patch-up 
the plasma membrane if GSDMD pores are below a certain threshold. 
 
Our results as previously described reports that K+ efflux from the cell can regulate 
DNA-induced type-I IFN production; thereby demonstrating the key role of K+ in 
GSDMD mediated suppression. The evidence in literature shows that K+ plays a key 
role in enzyme catalysis. K+ is abundant inside the cell and many cellular processes use 
it as a source of chemical potential to drive enzymatic catalysis (Gohara and Di Cera, 
2016). The data in this study, using a cGAS enzymatic assay demonstrates that K+ 
plays a role in cGAS-DNA interaction.  
This correlates with recent studies. Wang et al., show that Manganese (Mn) increases 
the sensitivity of cGAS-DNA interactions as well as its enzymatic activity in DNA virus 
infections (Wang et al., 2018). Another example of ion concentration influencing cGAS 
activity comes from the evidence that Zinc (Zn) enhances the catalytic activity of cGAS 
both in-vitro and in cell systems (Du and Chen, 2018). 
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Figure 1: Summary: Gasdermin-D suppresses cytosolic DNA-induced type-I IFN 
production by inducing K+ efflux. 
DNA in the cytoplasm activates cGAS-STING mediated IFN-β production and AIM2 
inflammasome induced GSDMD activation. GSDMD forms pores in the plasma 
membrane resulting in K+ efflux. The reduction in intracellular K+ concentration 
abrogates cGAS-DNA interactions, thereby suppressing the production of type-I IFN 
(Banerjee et al., 2018). 
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Significance 
 
Pathological conditions such as cancer can result in damage to the nuclear 
compartment. This can result in the presentation of the nuclear material to cytoplasmic 
host sensors. Nuclear self-DNA can thus be recognized by cytoplasmic DNA sensors 
cGAS and AIM2 (Di Micco et al., 2016). cGAS recognition of self DNA from dying tumor 
cells results in the production of type-I IFNs (Corrales et al., 2016). Additionally, cGAS 
mediated IFN production is essential for priming of CD8 T cells against tumor antigens 
(Deng et al., 2014). Moreover, intra-tumoral delivery of cGAMP leads to increased 
tumor regression and prolonged survival of tumor-bearing mice (Corrales et al., 2015; 
Demaria et al., 2015). cGAMP has also shown to be beneficial in combinatorial therapy 
with check-point blockade therapy such as antibodies against PD-1 and PD-L1 (Chen et 
al., 2016). 
 
 Activation of the inflammasome pathway by self-DNA can lead to the development of 
autoinflammatory diseases such as polyarthritis like symptoms caused in DNase II 
deficient mice (Baum et al., 2015; Jakobs et al., 2015). One of the most prominent auto-
inflammatory diseases associated with dysrerulated cGAS induced type-I IFN 
production is Acardi-Goutiers Syndrome. These patients typically have genetic defects 
in the exonuclease TREX-1that degrades single-stranded DNA or RNaseH2 that cuts 
RNA in RNA-DNA hybrids (Gao et al., 2015; Gray et al., 2015; McKenzie et al., 2016). 
Another auto-inflammatory disease associated with gain-of function mutations in STING 
is called STING-associated vasculopathy (SAVI) (Liu et al., 2014). Patients with this 
 49 
syndrome typically present with cutaneous inflammation, ulcers and necrotizing lesions 
and widespread pulmonary damage (Reviewed in: Chen et al., 2016).  
Therefore, the discovery of a novel regulatory mechanism for cGAS/STING-induced 
type-I IFN may have profound therapeutic implications in anti-tumor immunity and auto-
inflammatory and autoimmune diseases. 
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Chapter V 
Figures 
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Results of the presented work have been published in Banerjee et al., 2018. 
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Figure 1. 
AIM2 inflammasome activation suppresses cytosolic DNA-induced type I IFN 
production.  
 
(A and B) IL-1 β (A) and IFN-β (B) levels in the supernatants of Pam3CSK4-primed wild-
type (WT) and AIM2-/- BMDMs stimulated with F. novicida (MOI=50) or poly(dA:dT) for 6 
h. (C) Immunoblots of viperin, ISG15 and b-actin in the lysates of WT and AIM2-/- (KO) 
iBMDMs stimulated with F. novicida (MOI=100), poly(dA:dT), or Sendai virus for 8 h. (D 
to F) IFN- β levels in the supernatants of BMDMs from WT, Asc-/- (D), Caspase-1/11-/-
(E), and AIM2-/- (F) mice stimulated with indicated treatments for 6 h. (G-J) Cytokine 
levels in the plasma of WT or indicated KO mice infected s.c. with 5 Å~ 105 CFU of F. 
novicida. Cytokine levels were assessed 24 h post-infection (p.i). (K) Plasma IFN-b 
levels in WT and AIM2-/- mice 6 h after intraperitoneal infection with 1 Å~ 109 CFU of E. 
coli BL21. Data are from one experiment representative of three. In the bar graphs, data 
are presented as mean±SEM, and each dot represents a technical replicate. For G-K, 
each circle represents a mouse and the horizontal lines represent mean. IFN- β levels 
are presented as units/ml or pg/ml depending upon the recombinant IFN-β standard 
used in the ELISA. *, P <0.05; ns, not significant; two-way ANOVA followed by the 
Sidak’s post-test (A, B, D, and E) or unpaired two- tailed t test (G-K). 
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Figure 2.  
GSDMD is required for inflammasome-mediated suppression of type I IFN 
production.  
 
(A) Immunoblotting for cGAS and b-actin in the lysates and the cleaved caspase-1 (p20) 
in the methanol chloroform-precipitated supernatants of Pam3CSK4-primed WT 
BMDMs stimulated with F. novicida, poly(dA:dT), nigericin, or ATP. (B-D) IFN-β  
secretion (B), cell death (C), and IL-1 β  secretion (D) by Pam3CSK4-primed WT and 
GSDMD-/- iBMDMs stimulated with F. novicida or poly(dA:dT) for 6 h. (E-F) IFN-β  
secretion (E), LDH release, and intracellular ATP levels (F) in WT and GSDMD-/- 
primary BMDMs infected with F. novicida (MOI=100) at 4, 6, 8 and 12 h p.i. (G) IFN-β  
secretion and cell death in WT, caspase-11-/- and GSDMD-/- primary BMDMs infected 
with EHEC (MOI=50) at 16 h p.i.  
(H) IFN-β  levels in the supernatants of WT and GSDMD-/- BMDMs stimulated with 
Sendai virus or LPS for 6 h. (I-K) IFN-β (I) or IL-6 (J and K) levels in the supernatants of 
BMDMs of indicated genotypes infected with F. novicida (MOI of 12.5, 25 and 50) or 
Sendai virus for 6 h. (L and M) IFN-β levels in the plasma (L) and the bacterial load in 
the spleen and liver (M) of WT and GSDMD-/- mice infected s.c. with 1.5 Å~ 105 CFU of 
F. novicida at 24 h p.i. Each circle represents a mouse and the horizontal lines 
represent mean. (N) Survival of WT and GSDMD-/- mice (n=5) infected s.c. with 2.5 Å~ 
102 CFU of F. novicida. (O) Survival of WT and AIM2-/- mice (n=5) infected s.c. with 2.5 
Å~ 102 CFU of F. novicida and injected i.p. with 250 mg of an isotype control or anti-
IFNAR antibody 12 h p.i. Data are from one experiment representative of three (A-M) or 
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two (N and O) experiments. In the bar graphs, data are presented as mean±SEM, and 
each dot represents a technical replicate. For L-M, each circle represents a mouse and 
the horizontal lines represent mean. IFN-β levels are presented as units/ml or pg/ml 
depending upon the recombinant IFN-β  standard used in the ELISA. *, P <0.05; ns, not 
significant; two-way ANOVA followed by the Sidak’s post-test (B, C, D, and G), unpaired 
two-tailed t test (L and M), or Mantel-Cox test (N and O). See also Figure S1. 
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Figure 3.  
GSDMD suppresses cytosolic DNA-induced IFN-β by targeting cGAS.  
 
(A) Immunoblots of pIRF3, pTBK1, IRF3, and β-actin in the lysates of WT and 
GSDMD-/- BMDMs stimulated with indicated treatments for indicated times. Med, 
medium; Fn, F. novicida. (B) Immunoblots of pIRF3, pTBK1, IRF3, TBK1, and β-actin in 
the lysates of WT and AIM2-/- BMDMs stimulated with indicated treatments for 8 h. SeV, 
Sendai virus. (C-D) PCR analysis of F. novicida DNA recovered from cGAS 
immunoprecipitates from WT and GSDMD-/- BMDMs stimulated with F. novicida for 6 h. 
Agarose gel image of PCR products (C). Fold increase in cGAS-associated F. novicida 
DNA in GSDMD-/- BMDMs over that of wild-type BMDMs as revealed by quantitative 
PCR (D). Fn, F. novicida. (E) STING monomers and dimers in the lysates of WT and 
GSDMD-/- BMDMs stimulated with F. novicida (MOIs of 50 and 100), poly(dA:dT), or 
cGAMP for 6 h as assessed by nonreducing PAGE and immunoblotting. Med, medium. 
Data presented as mean±SEM are from one experiment representative of three. Each 
dot represents a technical (D) replicate. *, P <0.05; ns, not significant; unpaired two-
tailed t test (D).  
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Figure 4.  
GSDMD suppresses type I IFN production by inducing K+ efflux.  
 
(A) Cell death in WT BMDMs infected with F. novicida for 6, 12, 24 and 36 h in the 
presence or absence of glycine as assessed by LDH release. (B) Cell death in WT 
BMDMs infected with F. novicida for 6 h in the presence or absence of glycine as 
assessed by CytoTox Flo assay. (C) Cell death in and secretion of IFN-β by WT 
BMDMs infected with F. novicida for 6 h in the presence or absence of glycine. (D) IFN-
β levels in the supernatants of WT, IL1r-/- or IL18r-/- BMDMs following infection with F. 
novicida for 6 h. (E) IFN-β  levels in the supernatants of F. novicida-infected WT and 
IL18r-/- BMDMs treated with DMSO or IL-1R antagonist at the indicated concentrations. 
(F-H) Intracellular K+ levels as assessed by APG4 staining in WT, AIM2-/- (F), Caspase-
1/11-/- (G), and GSDMD-/- (H) in uninfected and F. novicida-infected BMDMs at 6 h p.i. 
(in the presence of glycine). (I to L) IFN- β  secretion, cell death (assessed by LDH 
release assay), and cell viability (assessed by CellTiter-Glo assay) in WT BMDMs 
stimulated with poly(dA:dT) or F. novicida as indicated for 6 h in DMEM (I and K) or 
isosmotic minimal medium (J and L) supplemented with indicated amounts of KCl.  
Data presented as mean±SEM are from one experiment representative of three. Each 
dot represents a technical replicate. IFN-β levels are presented as units/ml or pg/ml 
depending upon the recombinant IFN-β  standard used in the ELISA. *, P <0.05; ns, not 
significant; two-way ANOVA followed by the Sidak’s post-test. See also Figure S3. 
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Figure 5.  
Induction of K+ efflux in inflammasome-deficient macrophages is sufficient to 
restore cytosolic DNA-induced type I IFN response to wild-type levels.  
 
(A and B) IFN-β  levels in the supernatants of and intracellular K+ levels (at 6 h post-
stimulation) in RAW macrophages stimulated with F. novicida (MOI of 50) or 
poly(dA:dT) and treated at 2 h after stimulations with vehicle (ethanol), 2.5 or 5 mM 
nigericin (A) or 5 or 10 mM valinomycin (VM; B). (C) IFN-β  levels in the supernatants of 
RAW macrophages stimulated with poly(dA:dT), LPS (1 mg/ml) or poly(I:C) (40 mg/ml) 
and treated at 2 h after stimulations with 2.5 mM nigericin. (D) cGAMP levels in RAW 
macrophages 5 h after stimulated with F. novicida or poly(dA:dT) and treated at 2 h 
after stimulations with 2.5 mM nigericin. as measured by LC-MS. (E) Immunoblots of 
pIRF3, pTBK1, IRF3, TBK1 and b-actin in lysates of RAW macrophages stimulated with 
poly(dA:dT) or LPS and treated with vehicle (Veh) or 2.5 mM nigericin (Nig). (F and G) 
IFN-β levels in the supernatants of and intracellular K+ levels in WT and caspase-1/11- 
/- BMDMs (measured at 6 h post-infection) infected with F. novicida and treated with 
vehicle (ethanol), 2.5 mM nigericin (F), or 5 mM valinomycin (VM; G) 2 h post-infection. 
(H) IFN-β  levels in the supernatants of caspase-1/11-/- BMDMs (measured at 6 h post- 
stimulation) stimulated with poly(dA:dT), LPS, or poly(I:C) and treated with vehicle, 2.5 
mM nigericin or 5 mM valinomycin (VM). (I) IFN-β levels in the supernatants of F. 
novicida-, poly(dA:dT)-, or poly(I:C)-stimulated WT BMDMs incubated in isosmotic 
minimal medium containing 5 mM KCl and caspase-1/11-/- BMDMs incubated in 
isosmotic minimal medium containing 5 or 0 mM KCl. (J and K) IFN-β  levels in the 
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supernatants of WT and GSDMD-/- iBMDMs (measured at 6 h post-infection) infected 
with F. novicida and treated with vehicle, nigericin (J), or valinomycin (VM; K) at the 
indicated concentrations 2 h post-infection. (L) IFN-β levels in the supernatants of 
GSDMD-/- iBMDMs (measured at 6 h post-stimulation) stimulated with F. novicida, 
poly(dA:dT), LPS, or poly(I:C) and treated with vehicle, 2.5 mM nigericin, or 5 mM 
valinomycin (VM). 
(M-O) IFN-β levels in the supernatants of indicated macrophages (at 6 h post-
stimulation) stimulated with F. novicida (MOI of 50) or poly(dA:dT) and treated at 1.5 – 2 
h after stimulations with vehicle (ethanol) or increasing concentrations of nigericin 
(0.0125–2.5 mM). (P) IFN-β levels in the supernatants of and intracellular ATP levels in 
GSDMD-/- BMDMs (at 6 h post-stimulation) stimulated with F. novicida or LPS. After 1 h 
of stimulation cells were incubated in isosmotic minimal medium containing 5 mM or no 
KCl and 1 h later, KCl was added to cells incubated in isosmotic minimal medium 
without KCl to restore K+ concentration in the medium to 5 mM. Data presented as 
mean±SEM are from one experiment representative of three. Each dot represents a 
technical replicate. IFN-β levels are presented as units/ml or pg/ml depending upon the 
recombinant IFN-β  standard used in the ELISA. *, P <0.05; ns, not significant; two-way 
ANOVA followed by the Sidak’s post-test. See also Figures S3 and S4. 
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Fig. S1. Gasdermin D deficiency enhances cGAS-induced IFN-β response in primary BMDMs. 
Related to Figure 2.
(A) Immunoblot showing full length (FL) and cleaved N terminal fragment (NT) of gasdermin D in the lysates of 
wild-type and Gsdmd-/- iBMDMs untreated (Med, medium) or infected with F. novicida (Fn) for 6 h.
(B) IFN-β levels in the supernatants of wild-type and Gsdmd-/- primary BMDMs stimulated with poly(dA:dT), F. 
novicida or Sendai virus. IFN-β levels are presented as units/ml or ng/ml depending upon the recombinant IFN-β 
standard used in the ELISA.
(C) Histograms displaying fluorescence intensities of viperin in WT and Gsdmd-/-  iBMDMs stimulated with F. 
novicida, poly(dA:dT) or IFN-β. The fold increase in mean fluorescence intensity (MFI) of viperin in F. novicida-, 
poly(dA:dT)-, or IFN-β-treated over untreated cells (medium) is also shown.
(D)  IFN-β levels in the supernatants of wild-type and Nlrp3-/- primary BMDMs stimulated with F. novicida for 6 h. 
Data presented as mean are from one experiment representative of three experiments. In the bar graphs, each 
dot represents a technical replicate.
Me
diu
m
F. n
ovic
ida
Pol
y(d
A:d
T)
Sen
dai
 vir
us
0
500
1000
1500
IF
N
-β
 u
ni
ts
/m
l
WT
Gsdmd-/-
A B
0 102 103 104 105
0
20
40
60
80
100
0 102 103 104 105
0
20
40
60
80
100
0 102 103 104 105
0
20
40
60
80
100
0 102 103 104 105
0
20
40
60
80
100
Medium F. novicida Poly(dA:dT) IFN-`
Viperin (Mean fluorescence intensity)
WT GsdmD-/- Isotype
Me
diu
m
F. n
ovic
ida
Pol
y(d
A:d
T)
IFN
-β
0
10
20
30
V
ip
er
in
 M
FI
(F
ol
d 
in
cr
ea
se
 
ov
er
 m
ed
iu
m
)
WT
Gsdmd-/-
C
D
Me
diu
m
F. n
ovic
ida
0.0
0.5
1.0
1.5
IF
N
-β
 n
g/
m
l
WT
Gsdmd-/-
Nlrp3-/-
FL (~53.5 kDa)
NT (~30 kDa)
Med Fn
W
T
KO W
T
KO
-37
-50
kDa
 64 
 
 
 
 
 
 
Figure S2. 
 Glycine treatment prevents pyroptotic lysis without altering K+ efflux. 
(A) Cell Death (LDH release) and intracellular K+ levels in uninfected (medium) or F. 
novicida-infected wild-type (WT) BMDMs in the presence or absence of 50mM glycine 
(assessed at 6h post-infection). Note that glycine treatment reduces LDH release 
without affecting K+ efflux.  Data presented as mean are from one experiment 
representative of three experiments. In the bar graphs, each dot represents a technical 
replicate. 
 
 
 
Fig. S3. Glycine treatment prevents pyroptotic lysis without altering K+ efflux. 
Relat d to Figure 4.
(A) Cell death (LDH release) and intracellular K+ levels in uninfected (medium) or F. novicida-
infected wild-type (WT) BMDMs in the presence or absence of 50 mM glycine (assessed at 6 h 
post-infection). Note that glycine treatment reduces LDH release without affecting K+ efflux.
(B) Immunoblots of FLAG, gasdermin D and β-actin in the lysates of Gsdmd-/- iBMDMs 
reconstituted with the mpty vector (EV), WT gasder in D, or I105N mutant gasdermin D. 
Arrowhead indicates gasdermin D band.
Data presented as mean are from one experiment representative of three experiments. In the 
bar graphs, each dot represents a technical replicate.
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Figure S3. 
Cytosolic DNA-induced IFN-b was not affected by calcium ionophore (ionomycin) 
and calcium chelator (BAPTA-AM). Related to Figure 5. 
(A) LDH release (at 6h post-stimulation) by RAW macrophages stimulated with F. 
novicida (MOI of 50) or poly(dA:dT) and treated at 2h post-stimulations with vehicle 
(ethanol), 2.5 or 5 µM nigericin or 5 or 10 M valinomycin (VM) at indicated 
concentrations. (B) IFN-β secretion by RAW macrophages (measured at 6h post-
infection) infected with F. novicida and treated with vehicle (ethanol), 1µM inomycin or 
2.5 µM nigericin. (C) IFN-β secretion by BMDMs (measured at 6h post-infection 
transfected with poly(dA:dT), and treated with vehicle or 10µM BAPTA-AM. (D) LDH 
release by BMDMs of indicated genotypes (measured at 6h post-infection) infected with 
F. novicida and treated with vehicle (ethanol), nigericin or VM 2h post-infection at 
indicated concentrations. Data presented as mean are from one experiment 
representative of three experiments. In the bar graphs, each dot represents a technical 
replicate. 
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Fig. S4. Cytosolic DNA-induced IFN-β was not affected by the calcium ionophore (ionomycin) 
and calcium chelator (BAPTA-AM). Related to Figure 5. 
(A) LDH release (at 6 h post-stimulation) by RAW macrophages stimulated with F. novicida (MOI of 50) or 
poly(dA:dT) and treated at 2 h after stimulations with vehicle (ethanol), 2.5 or 5 µM nigericin or 5 or 10 M valinomycin 
(VM) at indicated concentrations. 
(B) IFN-β secretion by RAW macrophages (measured at 6 h post-infection) infected 
with F. novicida and treated with vehicle (ethanol), 1 µM ionomycin, or 2.5 µM nigericin.
(C) IFN-β secretion by BMDMs (measured at 6 h post-infection) transfected with poly(dA:dT), 
and treated with vehicle or 10 µM BAPTA-AM. 
(D) LDH release by BMDMs of indicated genotypes (measured at 6 h post-infection) infected with F. novicida and 
treated with vehicle (ethanol), nigericin, or valinomycin (VM) 2 h post-infection at the indicated concentrations.
Data presented as mean are from one experime t representative of three experi ents, a d each dot represents a 
technical replicate.
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Figure S4 
Induction of K+ efflux in inflammasome-deficient macrophages is sufficient to 
restore cytosolic DNA induced type-I interferon response to wild-type levels. 
Related to Figure 5. 
(A-C) Relative ATP levels and metabolic activity as measured by CellTiter-Glo and 
PrestoBlue assays, respectively, in indicated macrophages (at 6h post-stimulation) 
stimulated with F. novicida (MOI of 50) or poly(dA:dT) and treated at 1.5 - 2h post-
stimulations with vehicle (ethanol), or increasing concentrations of nigericin (0.0125-2.5 
µM). (D) IFN-β levels in supernatant of, intracellular ATP levela and metabolic activity as 
measured by CellTiter-Glo and PrestoBlue assays, respectively, in indicated 
macrophages (at 6h post-stimulation) stimulated with F. novicida (MOI of 50) or 
poly(dA:dT) and treated at 1.5 - 2h post-stimulations with vehicle (ethanol), or 
increasing concentrations of valinomycin (0.0125-2.5 µM). (E) IFN-β levels in 
supernatant of, intracellular ATP levels in indicated Casp1/11-/- BMDMs (at 6h post-
stimulation) stimulated with F. novicida (MOI of 50) or poly(dA:dT). At 1.5h p.i., cells 
were treated with vehicle or nigericin (100 nM) and at 1h the media was replaced with 
media without nigericin. Data presented as mean are from one experiment 
representative of three experiments and each dot represents a technical replicate. 
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Chapter VI 
Appendix 
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Results of the presented work have been published in Banerjee et al., 2018. 
Appendix: Table of Experimental Materials 
 
Experimental Models: 
Organisms/Strains 
 
  
Mouse: C57BL/6J 
 
The Jackson Laboratory  000664 
Mouse: B6N.129S2-
Casp1tm1Flv/J 
The Jackson Laboratory 016621 
Mouse: B6.129S7-I l1r1tm1Imx/J The Jackson Laboratory 003245 
Mouse: B6.129P2-I l18r1tm1Aki/J The Jackson Laboratory 004131 
 
Mouse: B6 GSDMD-/- Kayagaki et al., 2015. 
Genentech, CA 
 
N/A 
 
Mouse: B6 AIM2-/- Jones et al., 2010. 
Genentech, CA 
 
N/A 
 
Mouse: B6.129P2-
AIM2Gt(CSG445)Byg/J 
Rathinam et al., 2010. 
The Jackson Laboratory 
 
013144 
 
Mouse: B6 Caspase11-/- Kayagaki et al., 2011 
Genentech, CA 
 
N/A 
 
Mouse: B6 Nlrp3-/- Rathinam et al., 2012. N/A 
 
Mouse: B6 Asc-/- Rathinam et al., 2010. N/A 
 
Mouse: B6 cGAS-/- Suschuk et al., 2016. N/A 
 
Oligonucleotides 
 
  
Primers for F. novicida mglA gene 
Forward: 
AGCGATATAGTCCGCATGATCC 
Reverse: 
TGGAAACATCGGAGGAAAGGG 
 
This study N/A 
 
 
Sequence of DNA used in cGAS 
assay: 
ACA TCT AGT ACA TGT CTA 
GTC AGT ATC TAG 
Dr. S.N. Sarkar  N/A 
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TGA TTA TCT AGA CAT ACA 
TCT AGT ACA TGT CTA 
GTC AGT ATC TAG TGA TTA 
TCT AGA CAT GGA 
CTC ATC C 
 
Recombinant DNA   
pMSCV-puro Clontech Cat# K1062-1 
 
pMSCV-puro 2xFLAG-HA-
GSDMD 
This study (Genewiz) N/A 
 
pMSCV-puro 2xFLAG-HA I105N-
GSDMD 
This study (Genewiz) N/A 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 71 
REFERENCES  
 
 
Ablasser A., Bauernfeind F., Hartmann G., Latz E., Fitzgerald K.A., Hornung V. (2009).
RIG-I-dependent sensing of poly(dA:dT) through the induction of an RNA polymerase 
III-transcribed RNA intermediate. Nat. Immunol. 10:1065–1072. 
 
Aglietti, R.A., Estevez, A., Gupta, A., Ramirez, M.G., Liu, P.S., Kayagaki, N., Ciferri, C., 
Dixit, V.M., and Dueber, E.C. (2016). GSDMD p30 elicited by caspase-11 during 
pyroptosis forms pores in membranes. Proceedings of the National Academy of 
Sciences 113, 7858–7863.  
 
AhmadNejad P., Hacker H., Rutz M., Bauer S., Vabulas R.M., Wagner H. (2002).Bacteri
al CpG-DNA and lipopolysaccharides activate Toll-like receptors at distinct cellular 
compartments. Eur. J. Immunol 32:1958–1968. 
 
Auerbuch, V., Brockstedt, D.G., Meyer-Morse, N., O'Riordan, M., and Portnoy, D.A. 
(2004). Mice lacking the type I interferon receptor are resistant to Listeria 
monocytogenes. J Exp Med 200, 527–533. 
 
Banerjee, I., Behl, B., Mendonca, M., Shrivastava, G., Russo, A J., Menoret, A., Patel N 
V., Vella, A T., Vanaja S K V., Sarkar S N., Fitzgerald K A., Rathinam V A K. (2018). 
Gasdermin D restrains type I interferon responses to cytosolic DNA by disrupting ionic 
homeostasis. Immunity 49,  413-426. 
 
Barker, J. H., Weiss, J., Apicella, M. A. & Nauseef, W. M. Basis for the failure of 
Francisella tularensis lipopolysaccharide to prime human polymorphonuclear 
leukocytes. Infect. Immun. 74, 3277–3284 (2006). 
 
Baum, R. et al. Cutting edge: AIM2 and endosomal TLRs differentially regulate arthritis 
and autoantibody production in DNase II-deficient mice. J. Immunol. Baltim. Md 1950 
194, 873–877 (2015). 
 
Bergsbaken, T., Fink, S.L., and Cookson, B.T. (2009). Pyroptosis: host cell death and 
inflammation. Nat. Rev. Microbiol. 7, 99–109.  
 
Bossaller, L., Chiang, P.-I., Schmidt-Lauber, C., Ganesan, S., Kaiser, W.J., Rathinam, 
V.A.K., Mocarski, E.S., Subramanian, D., Green, D.R., Silverman, N., et al. (2012). 
Cutting edge: FAS (CD95) mediates noncanonical IL-1β and IL-18 maturation via 
 72 
caspase-8 in an RIP3- independent manner. The Journal of Immunology 189, 5508–
5512.  
 
Broz P, von Moltke J, Jones JW, Vance RE, Monack DM. Differential requirement for 
Caspase-1 autoproteolysis in pathogen-induced cell death and cytokine 
processing. Cell host & microbe. 2010;8:471–483. 
 
Burdette, D.L., Monroe, K.M., Sotelo-Troha, K., Iwig, J.S., Eckert, B., Hyodo, M., 
Hayakawa, Y., and Vance, R.E. (2011). STING is a direct innate immune sensor of 
cyclic di-GMP. Nature 478, 515–518. Chen, Q., Sun, L., and Chen, Z.J. (2016). 
Regulation and function of the cGAS–STING pathway of cytosolic DNA sensing. Nature 
Immunology 17, 1142–1149.  
 
Chao, K. L., Kulakova, L. & Herzberg, O. Gene polymorphism linked to increased 
asthma and IBD risk alters gasdermin-B structure, a sulfatide and phosphoinositide 
binding protein. Proc. Natl. Acad. Sci. U. S. A. 114, E1128–E1137 (2017). 
 
Chen, Q. et al. Carcinoma-astrocyte gap junctions promote brain metastasis by 
cGAMP transfer. Nature 533, 493–498 (2016). 
 
Chen, K. W. et al. Noncanonical inflammasome signaling elicits GSDMD–dependent 
neutrophil extracellular traps. Sci. Immunol. 3, eaar6676 (2018). 
 
Chiu Y.H., Macmillan J.B., Chen Z.J. 2009. RNA polymerase III detects cytosolic DNA 
and induces type I interferons through the RIG-I pathway. Cell 138:576–591. 
 
Clemens, D. L., Lee, B.-Y. & Horwitz, M. A. Virulent and Avirulent Strains of Francisella 
tularensis Prevent Acidification and Maturation of Their Phagosomes and Escape into 
the Cytoplasm in Human Macrophages. Infect. Immun. 72, 3204–3217 (2004). 
 
Collazo, C. M., Sher, A., Meierovics, A. I. & Elkins, K. L. Myeloid differentiation factor-88 
(MyD88) is essential for control of primary in vivo Francisella tularensis LVS infection, 
but not for control of intra-macrophage bacterial replication. Microbes Infect. 8, 779–790 
(2006). 
 
 
Conos, S.A., Chen, K.W., De Nardo, D., Hara, H., Whitehead, L., Núñez, G., Masters, 
S.L., Murphy, J.M., Schroder, K., Vaux, D.L., et al. (2017). Active MLKL triggers the 
 73 
NLRP3 inflammasome in a cell-intrinsic manner. Proceedings of the National Academy 
of Sciences 114, E961–E969.  
 
Corrales, L. et al. Direct activation of STING in the tumor microenvironment leads to 
potent and systemic tumor regression and immunity. Cell Rep. 11, 1018–1030 (2015). 
 
Corrales, L., Woo, S.-R., Williams, J.B., McWhirter, S.M., Dubensky, T.W., and 
Gajewski, T.F. (2016). Antagonism of the STING Pathway via Activation of the AIM2 
Inflammasome by Intracellular DNA. The Journal of Immunology 196, 3191–3198.  
 
Crow, M.K. (2016). Autoimmunity: Interferon α or β: which is the culprit in autoimmune 
disease? Nat Rev Rheumatol 12, 439–440. Crow, Y.J., and Manel, N. (2015). Aicardi-
Goutieres syndrome and the type I interferonopathies. Nature Reviews Immunology 15, 
429–440.  
 
Cui, Y., Yu, H., Zheng, X., Peng, R., Wang, Q., Zhou, Y., Wang, R., Wang, J., Qu, B., 
Shen, N., et al. (2017). SENP7 Potentiates cGAS Activation by Relieving SUMO-
Mediated Inhibition of Cytosolic DNA Sensing. PLoS Pathog 13, e1006156.  
 
Demaria, O. et al. STING activation of tumor endothelial cells initiates spontaneous 
and therapeutic antitumor immunity. Proc. Natl. Acad. Sci. USA 112, 15408–15413 
(2015). 
 
Delmaghani, S. et al. Mutations in the gene encoding pejvakin, a newly identified protein 
ofthe afferent auditory pathway, cause DFNB59 auditory neuropathy. Nat. Genet. 38, 
770–778 (2006). 
Delmaghani, S. et al. Hypervulnerability to Sound Exposure through Impaired Adaptive 
Proliferation of Peroxisomes. Cell 163, 894–906 (2015). 
 
Di Micco, A. et al. AIM2 inflammasome is activated by pharmacological disruption of 
nuclear envelope integrity. Proc. Natl. Acad. Sci. U. S. A. 113, E4671–4680 (2016). 
 
Ding, J., Wang, K., Liu, W., She, Y., Sun, Q., Shi, J., Sun, H., Wang, D.-C., and Shao, 
F. (2016). Pore-forming activity and structural autoinhibition of the gasdermin family. 
Nature.  
 
Dobbs, N. et al. STING Activation by Translocation from the ER Is Associated with 
Infectionand Autoinflammatory Disease. Cell Host Microbe 18, 157–168 (2015). 
 74 
 
Du, M. and Chen, Z.J. (2018). DNA-induced liquid phase condensation of cGAS 
activates innate immune signaling. Science. 
 
Eil, R., Vodnala, S.K., Clever, D., Klebanoff, C.A., Sukumar, M., Pan, J.H., Palmer, 
D.C., Gros, A., Yamamoto, T.N., Patel, S.J., et al. (2016). Ionic immune suppression 
within the tumour microenvironment limits T cell effector function. Nature 537, 539–543. 
 
Evavold, C.L., Ruan, J., Tan, Y., Xia, S., Wu, H., and Kagan, J.C. (2018). The Pore-
Forming Protein GSDMD Regulates Interleukin-1 Secretion from Living Macrophages. 
Immunity 
 
Fernandes-Alnemri T, et al. The pyroptosome: a supramolecular assembly of ASC 
dimers mediating inflammatory cell death via caspase-1 activation. Cell death and 
differentiation. 2007;14:1590–1604. 
  
Fernandes-Alnemri, T., Yu, J.-W., Datta, P., Wu, J., and Alnemri, E.S. (2009). AIM2 
activates the inflammasome and cell death in response to cytoplasmic DNA. Nature 
458, 509–513.  
 
Fernandes-Alnemri, T., Yu, J.-W., Juliana, C., Solorzano, L., Kang, S., Wu, J., Datta, P., 
McCormick, M., Huang, L., McDermott, E., et al. (2010). The AIM2 inflammasome is 
critical for innate immunity to Francisella tularensis. Nature Immunology 11, 385–393.  
 
Fink, S.L., and Cookson, B.T. (2005). Apoptosis, pyroptosis, and necrosis: mechanistic 
description of dead and dying eukaryotic cells. Infect. Immun. 73, 1907–1916.  
 
Fink, S. L. & Cookson, B. T. Caspase-1-dependent pore formation during pyroptosis 
leads to osmotic lysis of infected host macrophages. Cell. Microbiol. 8, 1812–1825 
(2006). 
 
Fink, S.L., Bergsbaken, T., and Cookson, B.T. (2008). Anthrax lethal toxin and 
Salmonella elicit the common cell death pathway of caspase-1-dependent pyroptosis 
via distinct mechanisms. Proceedings of the National Academy of Sciences 105, 4312–
4317.  
 
Gohara, D.W., and Di Cera, E. (2016). Molecular Mechanisms of Enzyme Activation by 
Monovalent Cations. J Biol Chem 291, 20840–20848.  
 75 
 
Gong, Y.-N., Guy, C., Olauson, H., Becker, J.U., Yang, M., Fitzgerald, P., Linkermann, 
A., and Green, D.R. (2017). ESCRT-III Acts Downstream of MLKL to Regulate 
Necroptotic Cell Death and Its Consequences. Cell 169, 286–300.e16.  
 
Gray, E.E., Winship, D., Snyder, J.M., Child, S.J., Geballe, A.P., and Stetson, D.B. 
(2016). The AIM2-like Receptors Are Dispensable for the Interferon Response to 
Intracellular DNA. Immunity 45, 255–266.  
 
Guo, H., König, R., Deng, M., Riess, M., Mo, J., Zhang, L., Petrucelli, A., Yoh, S.M., 
Barefoot, B., Samo, M., et al. (2016). NLRX1 Sequesters STING to Negatively Regulate 
the Interferon Response, Thereby Facilitating the Replication of HIV-1 and DNA 
Viruses. Cell Host & Microbe 19, 515–528.  
 
Gutierrez, K.D., Davis, M.A., Daniels, B.P., Olsen, T.M., Ralli-Jain, P., Tait, S.W.G., 
Gale, M., and Oberst, A. (2017). MLKL Activation Triggers NLRP3-Mediated Processing 
and Release of IL-1β Independently of Gasdermin-D. J Immunol 198, 2156–2164.  
 
Halapi, E. et al. A sequence variant on 17q21 is associated with age at onset and 
severity of asthma. Eur. J. Hum. Genet. EJHG 18, 902–908 (2010). 
 
Hall, J. D., Craven, R. R., Fuller, J. R., Pickles, R. J. & Kawula, T. H. Francisella 
tularensis replicates within alveolar type II epithelial cells in vitro and in vivo following 
inhalation. Infect. Immun. 75, 1034–1039 (2007). 
 
Hall, J. C. & Rosen, A. (2010).Type I interferons: crucial participants in disease 
amplification in autoimmunity. Nat. Rev. Rheumatol. 6, 40–49.  
 
He, W.-T., Wan, H., Hu, L., Chen, P., Wang, X., Huang, Z., Yang, Z.-H., Zhong, C.-Q., 
and Han, J. (2015). GSDMD is an executor of pyroptosis and required for interleukin-1β 
secretion. Cell Res. 25, 1285–1298.  
 
Henry, T., Kirimanjeswara, G.S., Ruby, T., Jones, J.W., Peng, K., Perret, M., Ho, L., 
Sauer, J.- D., Iwakura, Y., Metzger, D.W., et al. (2010). Type I IFN signaling constrains 
IL-17A/F secretion by gammadelta T cells during bacterial infections. The Journal of 
Immunology 184, 3755–3767.  
 
Hornung, V., and Latz, E. (2010). Intracellular DNA recognition. Nature Reviews 
Immunology 10, 123–130.  
 76 
 
Hornung, V., Ablasser, A., Charrel-Dennis, M., Bauernfeind, F., Horvath, G., Caffrey, 
D.R., Latz, E., and Fitzgerald, K.A. (2009). AIM2 recognizes cytosolic dsDNA and forms 
a caspase-1- activating inflammasome with ASC. Nature 458, 514–518. 
 
Huang MT, et al. Critical role of apoptotic speck protein containing a caspase 
recruitment domain (ASC) and NLRP3 in causing necrosis and ASC speck formation 
induced by Porphyromonas gingivalis in human cells. Journal of 
immunology. 2009;182:2395–2404. 
 
Jakobs, C., Perner, S. & Hornung, V. AIM2 Drives Joint Inflammation in a Self-DNA 
Triggered Model of Chronic Polyarthritis. PLOS ONE 10, e0131702 (2015). 
 
Jones, J.W., Kayagaki, N., Broz, P., Henry, T., Newton, K., O'Rourke, K., Chan, S., 
Dong, J., Qu, Y., Roose-Girma, M., et al. (2010). Absent in melanoma 2 is required for 
innate immune recognition of Francisella tularensis. Proceedings of the National 
Academy of Sciences 107, 9771–9776.  
 
Kailasan Vanaja, S., Rathinam, V.A.K., Atianand, M.K., Kalantari, P., Skehan, B., 
Fitzgerald, K.A., and Leong, J.M. (2014). Bacterial RNA:DNA hybrids are activators of 
the NLRP3 inflammasome. Proceedings of the National Academy of Sciences 111, 
7765–7770. 
Kanaar, R., Wyman, C. (2008). DNA repair by the MRN complex: break it to make it. 
Cell. 135(1),14-6. 
 
Kalliolias, G, D. & Ivashkiv, L. B. (2010). Overview of the biology of type I interferons. 
Arthritis Res. Ther. 12, S1  
 
Kang, M.-J. et al. GSDMB/ORMDL3 variants contribute to asthma susceptibility and 
eosinophil-mediated bronchial hyperresponsiveness. Hum. Immunol. 73, 954–959 
(2012). 
 
Katsnelson, M.A., Rucker, L.G., Russo, H.M., and Dubyak, G.R. (2015). K+ Efflux 
Agonists Induce NLRP3 Inflammasome Activation Independently of Ca2+ Signaling. J 
Immunol 194, 3937–3952.  
 
Kayagaki, N., Stowe, I.B., Lee, B.L., O'Rourke, K., Anderson, K., Warming, S., Cuellar, 
T., Haley, B., Roose-Girma, M., Phung, Q.T., et al. (2015). Caspase-11 cleaves 
 77 
GSDMD for non-canonical inflammasome signaling. Nature 526, 666–671.  
 
Kayagaki, N., Warming, S., Lamkanfi, M., Vande Walle, L., Louie, S., Dong, J., Newton, 
K., Qu, Y., Liu, J., Heldens, S., et al. (2011). Non-canonical inflammasome activation 
targets caspase- 11. Nature 479, 117–121.  
 
Kerur N., Veettil M.V., SharmaWalia N., Bottero V., Sadagopan S., Otageri P., 
Chandran B. (2011). IFI16 acts as a nuclear pathogen sensor to induce the 
inflammasome in response to Kaposi sarcoma-associated herpesvirus infection. Cell 
Host Microbe. 9:363–375. 
 
Konno, H., Konno, K., and Barber, G.N. (2013). Cyclic dinucleotides trigger ULK1 
(ATG1) phosphorylation of STING to prevent sustained innate immune signaling. Cell 
155, 688–698.  
 
Kontaki, E., and Boumpas, D.T. (2010). Innate immunity in systemic lupus 
erythematosus: Sensing endogenous nucleic acids. Journal of Autoimmunity 35, 206–
211.  
 
Kovacs, S.B., and Miao, E.A. (2017). Gasdermins: Effectors of Pyroptosis. Trends Cell 
Biol. 27, 673–684.  
 
Kranzusch, P.J., Lee, A.S.-Y., Berger, J.M., and Doudna, J.A. (2013). Structure of 
Human cGAS Reveals a Conserved Family of Second-Messenger Enzymes in Innate 
Immunity. Cell Rep 3, 1362–1368.  
 
Lamkanfi, M., Dixit, V.M. Mechanisms and functions of inflammasomes .  Cell . 2014 
;157:1013–1022. 
 
Latz E.,  Schoenemeyer A., Visintin A., Fitzgerald K.A., Monks B.G., Knetter C.F., Lien 
E., Nilsen N.J., Espevik T., Golenbock D.T. 2004. TLR9 signals after translocating from 
the ER to CpG DNA in the lysosome. Nat Immunol 5:190–198. 
 
Lee H.K., Lund J.M., Ramanathan B., Mizushima N., Iwasaki A. (2007). Autophagy-
dependent viral recognition by plasmacytoid dendritic cells. Science 315:1398–1401. 
 
 
 78 
Lei, Y., Wen, H., Yu, Y., Taxman, D.J., Zhang, L., Widman, D.G., Swanson, K.V., Wen, 
K.-W., Damania, B., Moore, C.B., et al. (2012). The mitochondrial proteins NLRX1 and 
TUFM form a complex that regulates type I interferon and autophagy. Immunity 36, 
933–946.  
 
Liang, Q., Seo, G.J., Choi, Y.J., Kwak, M.-J., Ge, J., Rodgers, M.A., Shi, M., Leslie, 
B.J., Hopfner, K.-P., Ha, T., et al. (2014). Crosstalk between the cGAS DNA sensor and 
Beclin-1 autophagy protein shapes innate antimicrobial immune responses. Cell Host & 
Microbe 15, 228–238.  
 
Liu, X., Zhang, Z., Ruan, J., Pan, Y., Magupalli, V.G., Wu, H., and Lieberman, J. (2016). 
Inflammasome-activated GSDMD causes pyroptosis by forming membrane pores. 
Nature 535, 153–158.  
 
Malik, M. et al. Toll-like receptor 2 is required for control of pulmonary infection with 
Francisella tularensis. Infect. Immun. 74, 3657–3662 (2006). 
 
Man, S.M., Karki, R., Malireddi, R.K.S., Neale, G., Vogel, P., Yamamoto, M., Lamkanfi, 
M., and Kanneganti, T.-D. (2015a). The transcription factor IRF1 and guanylate-binding 
proteins target activation of the AIM2 inflammasome by Francisella infection. Nature 
Immunology 16, 467–475. 
 
Man, S.M., Zhu, Q., Zhu, L., Liu, Z., Karki, R., Malik, A., Sharma, D., Li, L., Malireddi, 
R.K.S., Gurung, P., et al. (2015b). Critical Role for the DNA Sensor AIM2 in Stem Cell 
Proliferation and Cancer. Cell 162, 45–58.  
 
Martinon, F., Burns, K., and Tschopp, J. (2002). The inflammasome: a molecular 
platform triggering activation of inflammatory caspases and processing of proIL-beta. 
Mol Cell 10, 417– 426.  
 
Mayer-Barber, K.D., Andrade, B.B., Oland, S.D., Amaral, E.P., Barber, D.L., Gonzales, 
J., Derrick, S.C., Shi, R., Kumar, N.P., Wei, W., et al. (2014). Host-directed therapy of 
tuberculosis based on interleukin-1 and type I interferon crosstalk. Nature 511, 99–103.  
 
McNab, F., McNab, F., Mayer-Barber, K., Mayer-Barber, K., Sher, A., Sher, A., Wack, 
A., Wack, A., and O'Garra, A. (2015). Type I interferons in infectious disease. Nature 
Reviews Immunology 15, 87–103.  
 
Meunier, E., Wallet, P., Dreier, R.F., Costanzo, S., Anton, L., Rühl, S., Dussurgey, S., 
 79 
Dick, M.S., Kistner, A., Rigard, M., et al. (2015). Guanylate-binding proteins promote 
activation of the AIM2 inflammasome during infection with Francisella novicida. Nature 
Immunology 16, 476– 484.  
 
Moffat, T. The ‘Childhood Obesity Epidemic’: Med. Anthropol. Q. 24, 1–21 (2010). 
 
Moltke, von, J., Trinidad, N.J., Moayeri, M., Kintzer, A.F., Wang, S.B., van Rooijen, N., 
Brown, C.R., Krantz, B.A., Leppla, S.H., Gronert, K., et al. (2012). Rapid induction of 
inflammatory lipid mediators by the inflammasome in vivo. Nature 490, 107–111.  
 
Muñoz-Planillo, R., Kuffa, P., Martínez-Colón, G., Smith, B.L., Rajendiran, T.M., and 
Núñez, G. (2013). K+ Efflux Is the Common Trigger of NLRP3 Inflammasome Activation 
by Bacterial Toxins and Particulate Matter. Immunity 38, 1142–1153.  
 
Nacionales, D. C. et al. (2007). Deficiency of the type I interferon receptor protects mice 
from experimental lupus. Arthritis Rheum. 56, 3770–3783.  
 
Page, M.J., and Di Cera, E. (2006). Role of Na+ and K+ in Enzyme Function. 
Physiological Reviews 86, 1049–1092. Prindle, A., Liu, J., Asally, M., Ly, S., Garcia-
Ojalvo, J., and Süel, G.M. (2015). Ion channels enable electrical communication in 
bacterial communities. Nature 527, 59–63.  
 
Panganiban, R. A. et al. A functional splice variant associated with decreased asthma 
risk abolishes the ability of gasdermin B to induce epithelial cell pyroptosis. J. Allergy 
Clin. Immunol. (2018). doi:10.1016/j.jaci.2017.11.040 
 
Platanias, L. C. (2005). Mechanisms of type-I- and type-II-interferon-mediated 
signalling. Nat. Rev. Immunol. 5, 375–386.  
 
Raetz, C. R. H. et al. Discovery of new biosynthetic pathways: the lipid A story. J. Lipid 
Res. 50 Suppl, S103–108 (2009). 
 
Rathinam, V.A.K., and Fitzgerald, K.A. (2016). Inflammasome Complexes: Emerging 
Mechanisms and Effector Functions. Cell 165, 792–800.  
 
Rathinam, V.A.K., Jiang, Z., Waggoner, S.N., Sharma, S., Cole, L.E., Waggoner, L., 
Vanaja, S.K., Monks, B.G., Ganesan, S., Latz, E., et al. (2010). The AIM2 
inflammasome is essential for host defense against cytosolic bacteria and DNA viruses. 
 80 
Nature Immunology 11, 395–402.  
 
Rathinam, V.A.K., Vanaja, S.K., Waggoner, L., Sokolovska, A., Becker, C., Stuart, L.M., 
Leong, J.M., and Fitzgerald, K.A. (2012). TRIF Licenses Caspase-11-Dependent 
NLRP3 Inflammasome Activation by Gram-Negative Bacteria. Cell 150, 606–619.  
 
Rogers, C. et al. Cleavage of DFNA5 by caspase-3 during apoptosis mediates 
progression to secondary necrotic/pyroptotic cell death. Nat. Commun. 8, 14128 (2017). 
 
Roberts, Z.J., Goutagny, N., Perera, P.-Y., Kato, H., Kumar, H., Kawai, T., Akira, S., 
Savan, R., van Echo, D., Fitzgerald, K.A., et al. (2007). The chemotherapeutic agent 
DMXAA potently and specifically activates the TBK1-IRF-3 signaling axis. J Exp Med 
204, 1559–1569.  
 
Roth S., Rottach A., LotzHavla A.S., Laux V., Muschaweckh A., Gersting S.W., Muntau
A.C., Hopfner K.P., Jin L., Vanness K., Petrini J.H., Drexler I., Leonhardt H., Ruland J. (
2014). Rad50-CARD9 interactions link cytosolic DNA sensing to IL-1beta 
production. Nat. Immunol. 15:538–545. 
 
 
Runkel, F. et al., The dominant alopecia phenotypes Bareskin, Rex-denuded, and 
Reduced Coat 2 are caused by mutations in gasdermin 3. Genomics 84, 824-835 
(2004). 
 
Russo, H.M., Rathkey, J., Boyd-Tressler, A., Katsnelson, M.A., Abbott, D.W., and 
Dubyak, G.R.(2016). Active Caspase-1 Induces Plasma Membrane Pores That Precede 
Pyroptotic Lysis and Are Blocked by Lanthanides. The Journal of Immunology 197, 
1353–1367. 
 
Rühl, S., and Broz, P. (2015). Caspase-11 activates a canonical NLRP3 inflammasome 
by promoting K(+) efflux. European Journal of Immunology 45, 2927–2936.  
 
Santic, M., Molmeret, M., Klose, K. E., Jones, S. & Kwaik, Y. A. The Francisella 
tularensis pathogenicity island protein IglC and its regulator MglA are essential for 
modulating phagosome biogenesis and subsequent bacterial escape into the 
cytoplasm. Cell. Microbiol. 7, 969–979 (2005). 
 
 81 
Sborgi, L., Rühl, S., Mulvihill, E., Pipercevic, J., Heilig, R., Stahlberg, H., Farady, C.J., 
Müller, D.J., Broz, P., and Hiller, S. (2016). GSDMD membrane pore formation 
constitutes the mechanism of pyroptotic cell death. Embo J. e201694696.  
 
Schmid-Burgk, J.L., Gaidt, M.M., Schmidt, T., Ebert, T.S., Bartok, E., and Hornung, V. 
(2015). Caspase-4 mediates non-canonical activation of the NLRP3 inflammasome in 
human myeloid cells. European Journal of Immunology 45, 2911–2917.  
 
Schneider, W.M., Chevillotte, M.D., and Rice, C.M. (2014). Interferon-Stimulated 
Genes: A Complex Web of Host Defenses. Annu Rev Immunol 32, 513–545.  
 
Seo, G.J., Yang, A., Tan, B., Kim, S., Liang, Q., Choi, Y., Yuan, W., Feng, P., Park, H.-
S., and Jung, J.U. (2015). Akt Kinase-Mediated Checkpoint of cGAS DNA Sensing 
Pathway. Cell Rep 13, 440–449.  
 
Shi, J., Zhao, Y., Wang, K., Shi, X., Wang, Y., Huang, H., Zhuang, Y., Cai, T., Wang, F., 
and Shao, F. (2015). Cleavage of GSDMD by inflammatory caspases determines 
pyroptotic cell death. Nature 526, 660–665.  
 
Stark, G. R. & Darnell, J. E. The JAK-STAT Pathway at Twenty (2012). Immunity 36, 
503–514.  
 
Storek, K.M., Gertsvolf, N.A., Ohlson, M.B., and Monack, D.M. (2015). cGAS and Ifi204 
Cooperate To Produce Type I IFNs in Response to Francisella Infection. The Journal of 
Immunology 194, 3236–3245.  
 
Sun, L., Wu, J., Du, F., Chen, X., and Chen, Z.J. (2013). Cyclic GMP-AMP synthase is a 
cytosolic DNA sensor that activates the type I interferon pathway. Science 339, 786–
791.  
 
Suschak, J.J., Wang, S., Fitzgerald, K.A., and Lu, S. (2016). A cGAS-Independent 
STING/IRF7 Pathway Mediates the Immunogenicity of DNA Vaccines. J Immunol 196, 
310–316.  
 
Sollberger, G. et al. GSDMD plays a vital role in the generation of neutrophil 
extracellulartraps. Sci. Immunol. 3, (2018). 
 
Vanaja, S.K., Russo, A.J., Behl, B., Banerjee, I., Yankova, M., Deshmukh, S.D., and 
 82 
Rathinam, V.A.K. (2016). Bacterial Outer Membrane Vesicles Mediate Cytosolic 
Localization of LPS and Caspase-11 Activation. Cell 165, 1106–1119.  
 
Wang, C., Guan, Y., Lv, M., Zhang, R., Guo, Z., Wei, X., Du, X., Yang, J., Li, T., Wan, 
Y., et al. (2018). Manganese Increases the Sensitivity of the cGAS-STING Pathway for 
Double-Stranded DNA and Is Required for the Host Defense against DNA Viruses. 
Immunity.  
 
Wang, Y., Ning, X., Gao, P., Wu, S., Sha, M., Lv, M., Zhou, X., Gao, J., Fang, R., Meng, 
G., et al. (2017). Inflammasome Activation Triggers Caspase-1-Mediated Cleavage of 
cGAS to Regulate Responses to DNA Virus Infection. Immunity 46, 393–404.  
 
Wassermann, R., Gulen, M.F., Sala, C., Perin, S.G., Lou, Y., Rybniker, J., Schmid-
Burgk, J.L., Schmidt, T., Hornung, V., Cole, S.T., et al. (2015). Mycobacterium 
tuberculosis Differentially Activates cGAS- and Inflammasome-Dependent Intracellular 
Immune Responses through ESX- 1. Cell Host & Microbe 17, 799–810. 
 
Wilson, J.E., Petrucelli, A.S., Chen, L., Koblansky, A.A., Truax, A.D., Oyama, Y., 
Rogers, A.B., Brickey, W.J., Wang, Y., Schneider, M., et al. (2015). Inflammasome-
independent role of AIM2 in suppressing colon tumorigenesis via DNA-PK and Akt. Nat 
Med 21, 906–913.  
 
Unterholzner L., Keating S.E., Baran M., Horan K.A., Jensen S.B., Sharma S., Sirois C.,
Jin T., Xiao T., Fitzgerald P., Paludan S., Bowie A.G. 2010. IFI16 is an innate immune 
sensor for intracellular DNA. Nat. Immunol. 11:997–1004. 
 
 
Wu, J., Sun, L., Chen, X., Du, F., Shi, H., Chen, C., and Chen, Z.J. (2013). Cyclic GMP-
AMP is an endogenous second messenger in innate immune signaling by cytosolic 
DNA. Science 339, 826–830.  
 
Xia, P., Ye, B., Wang, S., Zhu, X., Du, Y., Xiong, Z., Tian, Y., and Fan, Z. (2016). 
Glutamylation of the DNA sensor cGAS regulates its binding and synthase activity in 
antiviral immunity. Nature Immunology 17, 369–378.  
 
Yasuda K.,Richez C.,  Uccellini M.B., Richards R.J., Bonegio R.G., Akira S., Monestier 
M., Corley R.B., Viglianti G.A., Marshak-Rothstein A., Rifkin I.R. (2009). Requirement 
for DNA CpG content in TLR9-dependent dendritic cell activation induced by DNA-
containing immune complexes. J Immunol 183:3109–3117. 
 83 
 
Zhang, L., Mo, J., Swanson, K.V., Wen, H., Petrucelli, A., Gregory, S.M., Zhang, Z., 
Schneider, M., Jiang, Y., Fitzgerald, K.A., et al. (2014). NLRC3, a member of the NLR 
family of proteins, is a negative regulator of innate immune signaling induced by the 
DNA sensor STING. Immunity 40, 329–341.  
 
Zhu, Q., Man, S.M., Karki, R., Malireddi, R.K.S., and Kanneganti, T.-D. (2018). 
Detrimental Type I Interferon Signaling Dominates Protective AIM2 Inflammasome 
Responses during Francisella novicida Infection. Cell Rep 22, 3168–3174. 
 
